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Reproductive senescence in females is a natural part of the aging 
process. However, the process by which it occurs, and the relative role of each 
level of the hypothalamic-pituitary-gonadal axis, remains largely unknown. The 
neural circuitry regulating the hypothalamic axis, including glutamate acting 
through N-Methyl-D-Aspartate receptors (NMDARs) on GnRH neurons, appears 
to be key to this process. The NMDAR is tetrameric and composed of an 
obligatory NR1 subunit together with NR2 subunits. The subunit composition 
determines the channel kinetics of the receptor and changes through the life 
span. This dissertation examines the physiological role of the NR2b subunit on 
LH pulsatile release and LH surge, both important for reproductive function. The 
expression of NR2b subunits in the anteroventral periventricular (AVPV) nucleus 
of the hypothalamus was also examined in aging rats. Experiment 1 showed that 
 vii 
the NR2b-antagonist, ifenprodil, enhanced pulsatile LH release in estradiol-
treated females (both age groups). Experiment 2 showed that the LH surge in 
middle-aged animals was slightly accelerated and that results were dependent 
upon prior reproductive status of the animals. In Experiment 3, examination of 
the NR2b-immunoreactive cell population in young, middle-aged, and aged 
ovariectomized females given vehicle, estradiol, or estradiol with progesterone 
showed an age-associated decline in NR2b density. However, the 
immunofluorescent fraction volume of NR1 colocalized with NR2b increased with 
aging, and that of immunofluorescent fraction volume of NR2b increased with 
estradiol treatment. This is indicative of the amount of protein expressed in the 
AVPV.  In total, NR2b cell density in the AVPV declines with age, but the amount 
of NR2b expressed in NR1-positive cells increases, suggesting a larger 
population of NR2b containing channels. This may translate to age-associated 
inhibition of GnRH/LH activity, which is relieved with blockade of NR2b-
containing NMDARs. Thus, this dissertation describes a novel way to examine 
the mechanism by which age-associated changes to neuromodulators of the 
HPG axis may affect the onset of reproductive senescence.  
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 Chapter 1. General Introduction 
As of 2006, the average life span of an American female was 80.4 years, 
an age that is nearly double that of the past century (National Center for Health 
Statistics, 2006). Greater life expectancy is accompanied by increasing concerns 
over age-related diseases, such as Alzheimer’s disease, cardiovascular disease, 
and stroke. Beyond this, half of the population, that is, all females, will eventually 
experience menopause. This natural progression is accompanied by a number of 
symptoms, including vasomotor symptoms, sleep disorders, depression, 
osteoporosis, cardiovascular morbidity, memory loss, and urogenital symptoms. 
Additionally, this increases a women’s risk to particular diseases, such as 
osteoporosis, cardiovascular disease, and endometrial cancer. Thus research to 
further understand this process and determine various mechanisms by which 
symptoms may be alleviated is vital for the maintenance of a woman’s quality of 
life both during and following this transition. 
Menopause is defined as the permanent cessation of menstruation and is 
typically associated with the depletion of ovarian follicles in humans (World 
Health Organization, 1996). This leads to a decline in estrogen levels, which has 
been attributed to the majority of symptoms and diseases mentioned previously. 
The STRAW panel has divided menopause into two stages, that of 
perimenopause and postmenopause (Soules et al., 2001). Perimenopause 
begins at approximately 47.5 years of age with the onset of symptoms 
associated with menopause, such as irregular menstrual cycles, decreased 
fecundity, and changes in hormone levels. Females are classified as 
perimenopausal until they have experienced one full year without a menstrual 
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cycle, upon which they are considered postmenopausal. Although 
perimenopausal symptoms may not appear until a women’s mid- to late- 40s, 
ovarian decline may begin as early as 30-35 years, with peak decline at 
approximately 38 years old (Zapantis and Santoro, 2003). 
Despite the universality of menopause among women, its mechanism 
remains largely unclear, and treatment to ease its symptoms is uncertain. 
Although menopause and its resulting symptoms have been attributed to the 
decline of the ovarian follicle, recent research using animal models has revealed 
an interaction of both neuroendocrine and ovarian events that lead to the 
transition to acyclicity (reviewed in (Wise et al., 1999)), suggesting the decline of 
the ovarian follicle is a proximal event leading to ovarian failure, but not the only 
event. In order to fully understand the mechanisms behind the onset of 
reproductive aging, it has become clear that the focus cannot remain solely on 
the ovary, but must be expanded to include the entire reproductive axis, and the 
neural inputs driving this axis. Thus, this dissertation focuses on the neural 
mechanisms involved in the onset of reproductive senescence, using the female 
rat as a model organism.  
 
I. THE HYPOTHALAMIC-PITUITARY-GONADAL (HPG) AXIS 
The development and maintenance of the hypothalamic-pituitary-gonadal 
(HPG) axis is both important and necessary for propagation of the species. The 
mechanism of this regulation is extremely complex and only beginning to be 
understood. There are multiple components to this axis, both at the level of the 
brain and the body, and these levels regulate one another. Interaction within this 
axis, as well as neural inputs to this axis, creates a network in which the 
communication of multiple components works together to insure efficient and 
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effective reproductive function. Throughout development, adulthood and 
senescence, changes to this network affect changes to reproductive function.  
The hypothalamus encompasses a relatively small area of the brain at the 
ventral portion of the diencephalon, just below the thalamus. It contains neurons 
that release the decapeptide GnRH into the portal capillary system, where it is 
transported to the anterior pituitary gland, located just below the brain. Here, 
GnRH binds to its receptors on the gonadotropes and stimulates the release of 
the gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone 
(FSH). These are released systemically, and target their receptors on the 
gonads, where they bind and stimulate the release of steroid hormones 
(estrogens, progestins, and androgens in both females and males). These sex 
steroid hormones are transported through the general circulatory system, and as 
part of their activities, they feed back onto the pituitary and hypothalamus, 
inhibiting the release of GnRH and LH, completing a negative feedback circuit. 
Additionally, in females, just prior to ovulation, the estrogen-induced negative 
feedback changes to positive via a mechanism that is still not entirely understood 
but undoubtedly involves steroid-sensitive inputs to GnRH neurons. This causes 
stimulation of GnRH and LH, resulting in the preovulatory GnRH/LH surge that 
triggers ovulation in the females of species with spontaneous ovulation, including 
primates and rodents.  
 
II. THE REPRODUCTIVE LIFE CYCLE IN FEMALES 
A. Development and attainment of reproductive competence 
Throughout the lifespan, the reproductive axis undergoes a series of 
changes. During late prenatal/early postnatal life, the HPG axis is hyperactive in 
a sexually dimorphic manner, contributing to sexual differentiation of the brain 
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(Gore, 2008; McCarthy, 2008). Later in postnatal life, this hyperactivity declines 
and the HPG axis enters a quiescent period during which GnRH release 
decreases, resulting in a decline of gonadotropin and steroid hormone levels. 
During the pubertal transition, the quiescent period ends, with basal GnRH 
levels, GnRH pulse frequency and pulse amplitude increasing, thereby activating 
the HPG axis, and resulting in the sexual maturation of the animal. This process 
includes the onset of folliculogenesis and ovulation in the female, 
spermatogenesis in the male, steroidogenesis in the gonads of both sexes, as 
well as the manifestation of reproductive behaviors. Although all three HPG 
levels become active during the pubertal period, the driving force is the 
hypothalamic GnRH neurons (Richter and Terasawa, 2001; Sisk and Foster, 
2004). However, GnRH neurons have the ability to release the GnRH 
decapeptide long before puberty. Therefore, the attainment of reproductive 
competence involves not only molecular modifications of gene and protein 
expression of GnRH (Ebling and Cronin, 2000; Sisk and Foster, 2004), but also, 
a maturation of the hypothalamic neural circuitry that regulates the GnRH cells 
(Ebling and Cronin, 2000; Gore, 2002a). Puberty involves changes in the 
excitatory and inhibitory neurotransmitters that regulate GnRH release, and 
specifically is characterized by decreased GABAergic inhibition of GnRH 
neurons, and an enhancement of facilitatory effects of glutamatergic inputs to the 
GnRH system, among other neurotransmitters that modulate the timing of 
puberty (Moguilevsky and Wuttke, 2001; Terasawa, 2005; Clarkson and 
Herbison, 2006).  
In female rats, once puberty has occurred, the adult animal experiences 
regular estrous cycles of 4-5 days that are divided into four phases: diestrus I, 
diestrus II, proestrus, and estrus. During diestrus I and II, GnRH and LH release 
are low, and estrogen (primarily estradiol) levels are at their lowest. As diestrus II 
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transitions to proestrus, estrogen levels increase and concurrently switch from 
exerting a negative feedback onto the hypothalamus and pituitary, to positive 
feedback. This results in the GnRH/LH surge that triggers ovulation during 
estrus. The timing of reproductive behaviors is also coordinated by these cyclic 
hormonal fluctuations, with females becoming sexually receptive during this 
transition to estrus, the time that maximizes the likelihood of successful 
fertilization upon mating (Gore, 2008; McCarthy, 2008). Although this dissertation 
focuses on the rat model, a species that exhibits short estrous cycles (as do 
mice), other vertebrates, including non-human and human primates, undergo 
similar developmental processes, with the capacity to generate menstrual cycles 
first occurring during pubertal development. This latter process, while much more 
prolonged than the rodent’s estrous cycle, also shares similar traits of negative 
and positive feedback of preovulatory GnRH/LH release (Figure 1.1) (Maffucci 
and Gore, 2005) 
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Fig. 1.1: The reproductive cycle of primates (menstrual cycle) and rodents 
(estrous cycle) 
 
Figure 1.1: The hormonal fluctuation inherent to a 28-day primate menstrual cycle (top) or a 4-5 
day rodent estrous cycle (bottom) is illustrated. Although these species experience a cycles of 
different durations, the hormonal fluctuation of gonadotropin-releasing hormone (GnRH), 
luteinizing hormone (LH), follicle-stimulating hormone (FSH), estrogen, and progesterone are all 
very similar. Prior to ovulation, estrogen levels increase and stimulate the release of GnRH and 
LH, resulting in the preovulatory surge necessary to initiate ovulation. 
Modified from Maffucci et al., 2005 
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Reproductive systems are subject to an array of biological clocks. A 
critical biological rhythm of reproduction is the pulsatile (circhoral) mode of 
release of GnRH, and subsequently LH. In rats, pulses of GnRH/LH occur at 
intervals of roughly 30 minutes (Scarborough and Wise, 1990), and in primates, 
the rhythm is on the order of every 1-2 hours (Terasawa, 1995, 2005). This 
mechanism is in place throughout the reproductive life of the organism, and is 
necessary for proper reproductive function (Belchetz et al., 1978; Wildt et al., 
1981; Loucopoulos et al., 1984). Notably, pulses of GnRH occur throughout 
reproductive cycles of females, and therefore are superimposed upon the longer 
cyclic changes in GnRH during estrous and menstrual cycles in rodents and 
primates, respectively. Even shorter biological rhythms of GnRH exist, as shown 
by electrophysiological recordings from GnRH neurons in explant cultures, with 
short (millisecond to second to minute) bursts of electrical activity, calcium 
currents, and fluxes in GnRH peptide. It has been proposed that the coordination 
of this activity results in the pulsatile GnRH pattern described above (Suter et al., 
2000; Abe and Terasawa, 2005). The reproductive axis of mammals is also 
subject to circadian/diurnal rhythms of 24 hours (de la Iglesia and Schwartz, 
2006). Additionally, at least some mammalian species exhibit seasonal rhythms 
of reproduction, and even more specifically, GnRH (Ebling and Cronin, 2000). 
Thus, in examining the development and maintenance of the female 
reproductive axis, all of these biological rhythms of reproduction must be 
considered. In this dissertation, I will focus on regulation of GnRH/LH pulsatile 
release and the preovulatory GnRH/LH surge.  
  
B. Reproductive senescence 
During aging, reproductive systems undergo declines in function. While 
this is most apparent in the case of women, who undergo menopause at mid-life, 
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animals also experience partial or total reproductive failure (Maffucci and Gore, 
2005). Rats have proven to be an interesting model for reproductive aging 
because they experience neuroendocrine changes prior to ovarian failure, the 
latter which occurs very late in life in rats relative to humans. At middle age 
(about 1 year), the rat estrous cycle becomes irregular, resulting in cycles greater 
than 5 days in length. As the animal ages further, it eventually undergoes a 
transition to an acyclic state, resulting in persistent estrus, in which no ovulation 
occurs (Figure 1.2). This transition is accompanied by an attenuation and decline 
of the preovulatory or steroid-induced GnRH/LH surge (Wise, 1984), as well as a 
diminution of the GnRH/LH pulsatile pattern (Maffucci et al., 2008). Additionally, 
changes to hypothalamic GnRH gene expression are seen (Rubin et al., 1997; 
Gore et al., 2000b; Miller and Gore, 2002; Bottner et al., 2007). However, 
because these changes precede the loss of ovarian cyclicity and the capacity to 
ovulate, and therefore a severe decline in estrogen levels, similar to that 
experienced by primates and mice is not observed (Figure 1.3). Thus, these data 
suggest that at least in rats, reproductive aging involves, and may even be 
causally linked to, a gradual failure of hypothalamic GnRH function.  
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Fig. 1.2: Hormone and cycle fluctuations during the transition to reproductive 
senescence 
 
Figure 1.2: Regularly cycling young female rats (panel A) have a 4-5 day estrous cycle, in which 
estradiol levels show a distinct increase during the transition to proestrus. This precedes the pre-
ovulatory GnRH/LH surge necessary for ovulation (not depicted). Middle-aged, regularly cycling 
rodents (panel B) demonstrate the same reproductive cycle as young female, with a slightly 
attenuated and delayed increase in estradiol, leading to an attenuated and delayed preovulatory 
surge and ovulation. The onset of irregular cycles alters this further, showing a longer (greater 
than 5 day) estrous cycle (panel C). Finally, middle-aged animals become acyclic (panel D), 
showing no fluctuation in hormone levels and no ovulation. 
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Fig. 1.3: Estradiol levels throughout the life cycle: primates, mice, and rats 
 
Figure 1.3: Estradiol levels in primates and mice (solid line) and rats (dotted line) throughout their 
reproductive life cycles are very similar, excepting the period of the reproductive transition 
(middle-age). While primates and mice experience a decline in estradiol levels in middle age, 
levels in rats remain high. This makes them a desirable model to study when examining 
neuroendocrine mechanisms of reproductive aging.   
Modified from Maffucci et al., 2005 
 
However, there may be substantial species differences in the mechanisms 
for reproductive senescence. Women undergo follicular loss at mid-life, making it 
very difficult to ascertain whether there are also neuroendocrine changes at this 
same time, not to mention the impossibility of measuring hypothalamic hormones 
in humans, as this is a highly invasive procedure. Such measurements have 
been made in the rhesus monkey, and Gore et al. (Gore et al., 2004) showed 
that pulsatile GnRH release increases in perimenopausal rhesus monkeys, 
presumably due at least in part to a loss of negative feedback from estradiol. 
Consistent with this finding, serum LH, FSH, and gonadotropin free-a subunit (a 
proxy for GnRH) showed increased levels of their release during the 
 11 
perimenopause in women and female monkeys (Hall et al., 2000; Gill et al., 
2002; Woller et al., 2002; Downs and Urbanski, 2006). However, later post-
menopausal women do show a decrease in LH pulse amplitude and inter-pulse 
interval (Genazzani et al., 1997; Hall et al., 2000), suggesting initial post-
menopausal increases in gonadotropins due to the relief of estrogen stimulated 
negative feedback, but an eventual reversal of this elevation with more years 
post menopause. Thus, while slight species differences may exist in hormonal 
profiles during this transition, likely due to the lack of ovarian degradation in the 
rat, overall trends in hormone release between aging rats and humans appear to 
be similar.  
In aging rats, despite these changes in pulsatile and surge release of 
GnRH, and aberrations in GnRH gene expression, there are actually relatively 
few changes that are intrinsic to GnRH neurons. That is, GnRH cell numbers and 
distributions change very little with aging (Rubin et al., 1984; Hoffman and Finch, 
1986; Witkin, 1986; Miller et al., 1990; Rubin et al., 1994; Funabashi and Kimura, 
1995; Miller and Gore, 2002). GnRH neuronal ultrastructure does appear to 
undergo age-associated changes (Romero et al., 1994), as does the association 
of GnRH cells with astrocytes (Cashion et al., 2003). Thus, I invoke the broader 
GnRH neural network – the GnRH neurons together with their direct and indirect 
inputs from neurons, glia, and steroid hormone feedback – as an instigator of 
reproductive aging. This hypothesis is supported by observations of age-related 
changes in function of hypothalamic neurotransmitters and neurotrophic factors, 
and expression of their receptors and steroid hormone receptors. Some of these 
changes may occur directly upon GnRH neurons, others upon the more 
extended circuit of cells that regulates the GnRH dendrites, perikarya and 
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neuroterminals more broadly. The net effect of these alterations with aging is a 
loss of drive upon GnRH release (Yin and Gore, 2006).  
 
III. NEUROMODULATION OF THE GNRH SYSTEM -- GLUTAMATE 
While the hypothalamus is considered to be the driving force of the 
reproductive axis, there are a number of neurotransmitter and neuropeptide 
systems that both directly and indirectly regulate the activity of this region, 
making these a primary target to study to understand the regulation of this 
system throughout the reproductive lifespan. Of these, the neurotransmitter 
glutamate is of particular interest, as it is the primary stimulatory neurotransmitter 
of the entire central nervous system, including the hypothalamus (van den Pol, 
2003). As such, it plays a key regulatory role in the control of GnRH neurons.  
 
A. The glutamate-GnRH connection 
Glutamate is a regulator of developmental-, adulthood- and age-related 
control of GnRH function. As the primary excitatory amino acid neurotransmitter, 
glutamate is widely expressed in cells throughout the central nervous system. 
This neurotransmitter has several classes of receptors, which in turn, are made 
up of subunits whose expression varies by developmental age, sex, and region 
(Gore, 2001; Brann and Mahesh, 2005; Clarkson and Herbison, 2006; 
Henderson, 2007). Of relevance to reproductive neuroendocrinology, GnRH 
neurons themselves express glutamate receptors, and this co-expression varies 
across the life cycle (Eyigor and Jennes, 1996; Gore et al., 1996; Eyigor and 
Jennes, 1997; Jung et al., 1998; Adams et al., 1999; Sim et al., 2000; Miller and 
Gore, 2002; Bailey et al., 2006). In addition, hypothalamic regions that mediate 
effects of steroid hormone negative and positive feedback are abundant in 
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glutamatergic receptors. Immunohistochemical and in situ hybridization studies 
examining glutamate receptor localization in the hypothalamus have shown their 
presence in medial and median preoptic nuclei (MPN, MePO) and surrounding 
areas, the arcuate (ARC), dorsomedial (DMH), and ventromedial hypothalamic 
(VMH) nuclei, supraoptic nucleus (SON), suprachiasmatic (SCN), and 
paraventricular nucleus (PVH) (reviewed in (Brann, 1995; Jennes et al., 2002)). 
Additionally, immunohistochemical analysis of glutamatergic fibers in the 
hypothalamus has shown many to be in close proximity with GnRH perikarya (in 
the septum-diagonal band and preoptic area of the hypothalamus) and GnRH 
axons (in the median eminence) (Eyigor and Jennes, 1996). Here, I focus on one 
specific glutamate receptor, the NMDA receptor (NMDAR), and provide evidence 
for the control of GnRH function via the interaction of glutamate with NMDARs, 
focusing specifically on how this regulation changes across the reproductive 
lifespan. 
B. The NMDAR structure, function, and implications 
There are three classes of ionotropic receptors to which glutamate binds, 
named after agonist binding. GnRH neurons express all of these: N-methyl-D-
aspartate (NMDA) (Gore et al., 1996; Gu et al., 1999; Gore et al., 2000a; Miller 
and Gore, 2002; Ottem et al., 2002); kainate (Eyigor and Jennes, 2000), and DL-
α-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid (AMPA) (Gu et al., 1999; 
Bailey et al., 2006). Furthermore, these receptors are present not only on GnRH 
perikarya themselves, but also in a number of hypothalamic nuclei implicated in 
GnRH secretory control. These include the anteroventral periventricular nucleus 
(AVPV), MPN, ARC, and median eminence (ME), the latter being an area rich in 
GnRH nerve terminals (Gu et al., 1999; Brann and Mahesh, 2005; Yin et al., 
2007). Activation of ionotropic receptors by glutamate has important effects on 
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GnRH activity and resulting reproductive function, and this likely occurs via both 
these direct and indirect circuits.  
Conventionally, ionotropic glutamate receptors are designated as NMDA 
and non-NMDA (AMPA and kainate) glutamatergic subtypes. Whereas evidence 
exists suggesting that all of these receptors influence the regulation of the female 
reproductive axis (reviewed in (Brann and Mahesh, 1994; Brann, 1995; Brann 
and Mahesh, 2005)), this dissertation focuses solely on the NMDAR. Previous 
studies support a strong regulatory effect of the NMDAR throughout development 
and into the transition to reproductive senescence, making it an excellent 
candidate for concentrated research into the role of this neurotransmitter on the 
onset of reproductive aging.  
The NMDAR is believed to be a tetrameric receptor (Laube et al., 1998; 
Mano and Teichberg, 1998; Rosenmund et al., 1998), and is composed of 
multiple subunits (NR1, NR2a-d, NR3a-b; Table 1.1). It is thought that this 
tetrameric structure is likely composed of two NR1 and two NR2 subunits, with 
the NR1 subunit being obligatory for proper functioning (Sydow et al., 1996). 
Relatively little is known about the NR3 family of subunits. NR3a is highly 
expressed in the developing rat brain and complexes with NR1 and NR1/NR2 
(Das et al., 1998), whereas NR3b is found predominantly in motor neurons 
(Chatterton et al., 2002). In the hypothalamus of the rat, NR1 and NR2a-b are 
abundant and are co-expressed on GnRH cell bodies located in the rostral 
hypothalamus (Meeker et al., 1994; Gore et al., 2000a; Herman et al., 2000; 
Eyigor et al., 2001; Miller and Gore, 2002). Furthermore, GnRH neuroterminals in 
the adult female rat co-express NR1 (Kawakami et al., 1998a). In the female 
mouse, the NR2b and NR2d subunit mRNA have been detected in GnRH 
neurons of the hypothalamus (Todman et al., 2005), and NR1 protein was found 
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to co-express with GnRH (Adjan et al., 2008). Thus, this receptor likely regulates 
the GnRH system both directly and indirectly.  
 
Table 1.1: The NMDA receptor, subunits, and corresponding pharmacological 
agents 
 
Ligand 
Glutamate: endogenous ligand, binds to all glutamate receptors 
 
Receptor type Receptor 
subunits 
Agonist Antagonist 
NMDA receptor NR1 
NR2a, 2b, 2c, 2d 
NR3a, 3b 
NMDA (N-methyl-D-aspartate), 
NMA (N-methyl-D,L-aspartate): 
specific agonists of NMDA 
receptors 
MK-801: non-competitive 
NMDA receptor antagonist 
AP-5 or AP-7: competitive 
NMDA receptor antagonist 
Ifenprodil: Selective NR2b 
subunit antagonist 
 
Evidence suggests that the dominant NMDAR compositions for the 
hypothalamus are likely NR1/NR2a, NR1/NR2b, or NR1/NR2a/NR2b. Although 
the relative distribution of these stoichiometries have not been determined in the 
hypothalamus, Luo et al. (Luo et al., 1997) have suggested that the 
triheteromeric complex (NR1/NR2a/NR2b) is the most abundant in the adult rat 
cortex.  
The receptor itself requires binding of the co-agonist glycine along with a 
glutamate agonist to affect a response (Collingridge et al., 1983; Kleckner and 
Dingledine, 1988). At resting potential, magnesium acts as a voltage-dependent 
channel block, which can be removed with depolarization (Nowak et al., 1984). 
Once depolarization occurs, calcium, as well as sodium and potassium, can pass 
through the channel, affecting a response. The calcium permeability also makes 
these channels at risk for overexcitation resulting in neurotoxicity, cell injury, and 
death. As such, this receptor has been implicated in a number of diseases, 
including, acute neurological insult, chronic disorders such as Parkinson’s 
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disease and Alzheimer’s, and metabolic disorders including hypo- and 
hyperglycemia (reviewed in (Lynch and Guttmann, 2001)). Overall, these 
receptors are ubiquitous in the brain and are necessary for proper function.  
The composition of the NMDAR is important in determining a number of 
NMDAR properties. This includes post-translational modifications such as 
phosphorylation of the receptor and associations with intracellular proteins 
(Kennedy and Manzerra, 2001; Wenthold et al., 2003; Salter and Kalia, 2004). Of 
great importance is its association with the postsynaptic density-95 (PSD-95) 
family of membrane-associated guanylate kinases, which are determinant of the 
receptor expression at the synapse. These scaffolding proteins are important in: 
1. the promotion of NMDAR clustering; 2. the regulation of NMDAR activity via 
phosphorylation and dephosphorylation; 3. the regulation of NMDAR cell-surface 
expression via delivery and endocytosis; 4. inhibition of NMDAR cleavage; and 5. 
modulation of NMDAR channel properties (reviewed in (Stephenson, 2006)). As 
a ligand-gated channel, this receptor initiates down-stream signaling of a variety 
of pathways, including protein kinase A and C, tyrosine kinases, neuronal nitric 
oxide synthase, calmodulin kinases, calcineurin, CREB pathways, and structural 
and trafficking proteins (reviewed in (Stephenson, 2006)) and as such is 
implicated in a number of neuronal functions. In fact, a recent study suggests that 
estrogen regulates the interaction of PSD-95, nitric oxide synthase, and the 
NMDAR-NR2b subunit, suggesting a modulatory function of steroid hormones in 
determining the synaptic population of these receptors in the hypothalamus 
(d'Anglemont de Tassigny et al., 2007).  
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Additionally, the subunit composition dictates the pharmacological and 
kinetic properties of the receptor (Williams et al., 1994; Vicini et al., 1998; Paoletti 
et al., 2000; Lynch and Guttmann, 2001; Erreger et al., 2004). Whereas the NR1 
subunit is obligatory, the NR2 contribution determines these receptor properties. 
This expression pattern of these receptors changes both with development as 
well as within specific brain nuclei. Regions of the cortex, hippocampus, and 
hypothalamus have all shown temporal differences in NR2a and NR2b 
expression (Monyer et al., 1994; Sheng et al., 1994; Flint et al., 1997; Adams et 
al., 1999). Further ageing-associated changes to the NR2b subunit have been 
demonstrated in these regions (Gore et al., 2000a; Kuehl-Kovarik et al., 2000; 
Magnusson, 2000; Gore et al., 2002; Miller and Gore, 2002). Functionally, this 
translates to differential channel properties, resulting in developmental and 
activity-dependent regulation of various neuronal processes.  
Electrophysiology studies in HEK293 cells suggest that there is a distinct 
difference in the functioning of an NR1/NR2a and an NR1/NR2b receptor (Vicini 
et al., 1998; Chen et al., 1999; Erreger et al., 2005). The NR1/NR2a channel had 
a much higher probability to open at least once with a glutamate application, and 
once activated, demonstrated a higher peak open probability as well as a high 
probability to open (Chen et al., 1999; Erreger et al., 2005). Erreger et al. (2005) 
also determined that NR1/NR2b channels, once opened, had a longer duration of 
activation with a broader distribution, which generally indicates a slower 
deactivation time. It was also shown that there is a series of conformational 
changes that occur during the activation of both of these channels, and at least 
one of the events in this series is much faster for the NR1/NR2a than the 
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NR1/NR2b (Erreger et al., 2005). Finally, the NR1/NR2b configuration shows a 
slower deactivating current, at least in part due to a slower recovery from 
desensitization as compared to the NR1/NR2a receptor (Vicini et al., 1998). 
Based on these findings of temporal and spatial differences in NMDAR 
stoichiometry as well as differences in NMDAR function, it is likely that changes 
to NMDAR composition occurring at the time of the reproductive transition may 
influence the observed changes to reproductive function. Moreover, the steroid 
hormone environment modulates the properties of NMDARs (Carbone et al., 
1992; Brann et al., 1993a; Gazzaley et al., 1996; Gu et al., 1999; Gore et al., 
2002; Gureviciene et al., 2003; Adams et al., 2004; d'Anglemont de Tassigny et 
al., 2007), making those cells that express the receptors potential targets of 
integration of steroid hormone influences on HPG function.  
 
C. The glutamate-GnRH connection and reproductive senescence   
1. Adulthood 
1a. NMDAR actions upon the GnRH/LH surge 
As mentioned previously, reproductive physiology in adult females 
involves several rhythms of GnRH/LH release. Of primary interest to reproductive 
physiologists studying species with spontaneous ovulatory cycles, such as rats 
and primates (both human and non-human), are the patterns of GnRH/LH 
pulsatile release and the GnRH/LH surge that precedes ovulation. Both of these 
events are influenced by the action of NMDARs. With respect to the activation of 
GnRH gene expression and release during the surge, NMDAR activation in 
proestrous young adult female rats (Gore et al., 2000a) led to rapidly increased 
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GnRH gene expression in the hypothalamus (Table 1.2). The NMDAR antagonist 
MK-801 (Table 1.1) given to proestrous females not only blocked the LH surge, 
but also resulted in a less prominent increase in GnRH mRNA expression in the 
hypothalamus as compared to controls (Suzuki et al., 1995). Furthermore, 
application of AP-7 (NMDA antagonist; Table 1.1) into the third ventricle of OVX, 
E2 replaced females blocked the steroid-induced LH surge (Lopez et al., 1990), 
as did administration of MK-801 to the proestrous female (Brann and Mahesh, 
1991b). Administration of NMDA or NMA (Table 1.1) on the morning of proestrus 
resulted in an increase in LH levels shortly after (Brann and Mahesh, 1992; 
Luderer et al., 1993). Thus, activation of glutamate receptors contributes to the 
onset of the preovulatory LH surge, with roles being played by both NMDA and 
non-NMDA receptors.  
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Table 1.2: Effects of NMDA receptor agonists/antagonists on GnRH gene 
expression 
 
Technique Age, hormonal 
status  
Steroid 
hormone 
treatment 
Drug 
administration 
Effect on GnRH gene 
expression 
RNase 
protection 
assay 
Intact female rat 
pups, postnatal 
days 0, 5, 10, 15 
N/A NMA or MK-801 Little effects of NMA or MK-
801 on GnRH mRNA or 
primary transcripta 
RNase 
protection 
assay 
Intact pubertal rats, 
beginning day 25 
through the day of 
VO 
N/A NMA twice daily ⇑ GnRH mRNAb 
Northern 
blot 
hybridization 
Peripubertal (P28) 
OVX rats 
Estradiol/ 
progesterone 
MK-801 ⇓ in GnRH mRNA in rostral 
hypothalamusc 
RNase 
protection 
assay 
a. Young intact 
(proestrus) 
b. Middle-aged 
intact (proestrus or 
PE) 
N/A NMA a. ⇑ GnRH mRNA in POA 
b. ⇓ GnRH mRNA in POAd 
Quantitative 
RT-PCR 
Proestrous female 
rats 
N/A MK-801 Attenuation of the increase 
in GnRH mRNA during the 
GnRH/LH surgee 
In situ 
hybridization 
OVX adult rats Estradiol a. NMDA 
b. MK-801  
a. ⇑ GnRH mRNA 
b. ⇓ GnRH mRNAf  
Abbreviations: OVX, ovariectomized; PE, persistent estrus; VO, vaginal opening;  
⇓ decrease; ⇑ increase. 
 
a. Adams, M. M. et al., 1999; b. Gore, A. C. et al., 1996; c. Seong, J. Y. et al., 1993; d. Gore, A. 
C. et al., 2000b; e, Suzuki, M., et al., 1995; f, Ottem, E. N. et al., 2002. 
 
1b. NMDAR effects on pulsatile GnRH/LH release 
NMDAR agonists and antagonists affect the pulsatile release of GnRH 
and LH in a similar manner to their effects on the GnRH/LH surge. Agonists to 
both receptor types facilitate, and antagonists diminish/block, pulsatility. For 
example, pulsatile release of GnRH in vitro and LH release in vivo was 
diminished by administration of antagonists to NMDARs in both adult male and 
female rats (Arslan et al., 1988; Bourguignon et al., 1989b; Ping et al., 1994a, 
1995; Maffucci et al., 2008).  
In vitro studies on explanted hypothalami have further implicated 
glutamate receptors as key regulatory factors of GnRH output. Application of AP-
5 (NMDAR antagonist) to male hypothalamic retrochiasmatic explants resulted in 
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an inhibition of GnRH output (Bourguignon et al., 1989a). Analysis of NMDA 
application to median eminence fragments from the OVX female in the absence 
of estrogen demonstrated similar increases of GnRH output (Kawakami et al., 
1998a). Donoso et al. (Donoso et al., 1990) found that administration of the 
agonist NMDA to ME fragments that had been explanted from male adult rats 
caused an increase in GnRH output in vitro. It should be noted that most of these 
latter studies focused on GnRH nerve terminals in the median eminence, a 
region where NMDARs are expressed (Unnerstall and Wamsley, 1983; Maragos 
et al., 1988).  
In vivo experiments further highlight the role of these receptors in adult 
reproductive physiology. Repeated injections of NMA (i.v.) to intact (Abbud and 
Smith, 1991) or NMA (i.v.) to OVX (Pohl et al., 1989) female rats significantly 
increased LH release. Again these findings support the potential for modulation 
of gonadotropin output by NMDAR activation.  
 
1c. Steroid modulation of NMDAR’s effects on GnRH neurons 
The steroid hormone environment has considerable effects on NMDA 
receptor activation of GnRH neurons and has been studied at length in adult 
females. This is an important area of research because GnRH neurons do not 
express nuclear estrogen receptor (ER) alpha (Shivers, 1983) and although they 
express estrogen receptor beta (ERβ), this is not adequate to explain positive 
feedback effects of steroids upon the GnRH/LH surge (Wintermantel et al., 
2006). Thus, effects of estradiol and progesterone on this event are mediated to 
a large extent indirectly by inputs to GnRH cells. Observations that hypothalamic 
inputs to GnRH neurons express ERα corroborate this idea. In the case of 
glutamatergic regulation, immunohistochemical analyses show that steroid 
hormone receptors (ERα, ERβ, androgen receptor) are co-expressed with 
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NMDARs in various nuclei of the hypothalamus that are important to regulation of 
GnRH release (Diano et al., 1997; Chakraborty et al., 2003a, b). Examination of 
estradiol effects of NR1 expression in the AVPV found no effect on NR1 
immunoreactive cell numbers (Chakraborty et al., 2003b). To my knowledge, 
effects of estrogen on the expression of the remaining NMDA receptor subunits 
have not been examined, and this is one undertaking of this dissertation (see 
chapter 5).  
It appears that the duration of estrogen treatment, as well as the time of 
day that the endpoints are examined, play a role in determining actions of 
glutamate receptors on GnRH output. In general, estradiol enhances NMDA-
induced LH release (Arias et al., 1993; Maffucci et al., 2008). An examination of 
both GnRH and NMDAR subunit mRNA expression in response to different 
durations of estradiol treatment suggested little effect of duration in the POA-AH 
(Brann et al., 1993a; Miller and Gore, 2002; Ottem et al., 2002), but slight 
differences in the median eminence/medial basal hypothalamus (Miller and Gore, 
2002). Additionally, while NMDA administered in the morning (0700h) increased 
GnRH mRNA levels in OVX, estrogen treated females, MK801 administered in 
the afternoon (1200h) did not block the estrogen induced increase in GnRH 
mRNA levels that accompanies the estrogen-induced surge (Ottem et al., 2002). 
Examination of MK-801 administration in the morning was not examined. Finally, 
NMDA administration stimulated LH release in OVX, estradiol-primed females, 
but showed no effect in the absence of estradiol (Arias et al., 1993). Thus 
estradiol is a powerful regulatory factor in the modulation of this system by 
glutamate and its receptors.   
 
1d. Glutamate release in the hypothalamus-preoptic area 
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The ability of glutamate to activate GnRH release is clearly contingent 
upon its release at GnRH cell bodies, terminals, and dendrites. However, 
relatively little is known about this phenomenon in adult rats. Measurement of 
glutamate release in the POA show that it is increased during the steroid 
hormone-induced LH surge in adult female rats as measured by push-pull 
perfusion (Ping et al., 1994b; Jarry et al., 1995) and microdialysis sampling 
(Neal-Perry et al., 2005). These results are consistent with the proposed 
stimulatory role of glutamate during the GnRH/LH surge. 
 
2. Reproductive Senescence 
2a. Age-related changes in hypothalamic NMDA receptors 
Middle-aged rats experience a reproductive decline that results in 
decreased fertility and fecundity. Previous studies support that some of these 
changes are effected at the hypothalamic level, and that excitatory amino acids 
are strongly implicated. Age-associated changes in expression of NMDARs in the 
hypothalamus have been shown that may underlie some of these functional 
differences. Gene expression of NR1, NR2a and NR2b subunits were measured 
in the POA-AH and medial basal hypothalamus (MBH) of young, middle-aged, 
and aged intact animals of known cycling statuses (Gore et al., 2000a). NR2a 
and NR2b mRNA expression in the POA-AH were higher in cycling (both young 
and middle-aged) than acyclic (both middle-aged and aged) animals. In the MBH 
there was an overall increase in NR1, NR2a, and NR2b subunit mRNA 
expression with age. While this study showed no significant change in NR1 gene 
expression in POA-AH, by contrast, Zuo et al. (Zuo et al., 1996) found a decline 
in NR1 gene expression in both POA-AH and MBH regions in middle-aged 
versus young proestrus females using RT-PCR. The inconsistencies in findings 
may be due to the varied techniques used in each study, including tissue 
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dissection, variation in times of sacrifice, mRNA extraction, and mRNA 
processing. However, both studies support the presence of important changes in 
NMDAR stoichiometry based on cycle status and age.  
Ovariectomized rats have also been used to examine age-related changes 
in gene and protein expression of NMDAR subunits. Using young, middle-aged 
and old female rats that were OVX and given estradiol or vehicle treatment, 
Gore’s laboratory (Miller and Gore, 2002) showed significant effects of both age 
and hormone treatment on NMDAR subunit mRNA expression. Specifically, in 
POA, NR1 mRNA levels were significantly decreased by short-term (2 day) but 
not longer-term (2 week) estradiol. NR2a mRNA levels were also down-regulated 
by estradiol, particularly in middle-aged and old rats. NR2b mRNA levels were 
highest in old rats and treatment with estradiol increased these levels in the old 
group. In the MBH, NR1 mRNA levels were decreased in estradiol compared to 
vehicle treatment; NR2a mRNA was not affected by age or estradiol; and NR2b 
expression was up-regulated by 2 week estradiol treatment in young rats, and 
decreased by this treatment in old rats (Miller and Gore, 2002). Therefore, these 
studies show the importance of regional specificity in the expression of these 
receptors, as results differed between the POA-AH and MBH.  
To further pinpoint the anatomical site at which estradiol may regulate 
NMDAR expression, the number of cells expressing the NR1 protein was 
quantified in the AVPV of OVX, estrogen or cholesterol treated aging female rats, 
a region chosen for its importance in the preovulatory GnRH/LH surge (Terasawa 
et al., 1980; Wiegand et al., 1980). Results of quantitative stereology showed no 
effect of estradiol, but significant age-associated declines in NR1 immunoreactive 
cell numbers in the lateral AVPV (Chakraborty et al., 2003b). Other NMDAR 
subunits have not been quantified in this region. A goal of the current dissertation 
was to quantify numbers of the NMDAR-NR2b subunit immunoreactive cells in 
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the AVPV, and the effects of steroid hormone treatment on their expression (see 
chapter 5).  
 
2b. Co-expression of NMDA receptor subunits on GnRH neurons, and changes 
with age 
By examining NMDAR protein expression changes directly on GnRH 
neurons of the OVLT-POA hypothalamic region, our lab has demonstrated no 
age-related change in NR1 co-expression, but an increase in the NR2b subunit 
co-expression with GnRH from young to middle-aged intact animals (Miller and 
Gore, 2002). Further, co-expression of NMDAR subunits on GnRH neurons 
during the steroid-induced LH surge, a time when the GnRH response to 
glutamate agonists in vitro is attenuated in middle-aged females (Zuo et al., 
1996), showed a decline in expression between middle-aged and young rats.  
Thus, there may be a change in the stoichiometry of the NMDAR on 
GnRH cells with aging, that may underlie some of the functional differences in 
the responsiveness of GnRH neurons to NMDAR agonists, as described below 
(see section 4c). 
 
2c. Functional changes in responsiveness of GnRH neurons to glutamate with 
aging 
Pharmacological studies addressed some of the functional consequences 
in changes in NMDAR stoichiometry and/or expression of NMDARs in 
hypothalamus and on GnRH neurons. In vitro application of NMDA to anterior 
POA-MBH fragments from young and aged OVX females resulted in increases in 
GnRH peptide concentrations, with young females showing a greater increase 
than the aged group (Arias et al., 1996). In this same study, in vivo administration 
of NMDA to the POA resulted in a greater LH response of the young animals 
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compared to aged females, and baseline LH levels prior to NMDA administration 
were higher in the young animals (Arias et al., 1996). Zuo et al. (Zuo et al., 1996) 
performed a similar study using ARC/median eminence fragments from intact, 
proestrus young and middle-aged females. No age-associated differences were 
seen in basal GnRH output, but application of NMDA caused increases in GnRH, 
with a significantly greater effect in young explants. Furthermore, young animals 
had significantly higher levels of LH than middle-aged. However, this study did 
not measure the effect of in vivo NMDA application on LH levels.  
In assessing GnRH gene expression, NMA application to intact young and 
middle-aged female rats resulted in an increase in young, but a decrease in 
middle-aged animals (Gore et al., 2000a). Thus, while GnRH release appears to 
be stimulated by NMDAR agonists, there appears to be an age-associated 
disconnection between release and GnRH mRNA, as well as an attenuation of 
the NMDA effect.  
 
2d. Age-related changes in hypothalamic glutamate release 
Glutamate levels in the POA decline during aging, as shown in vitro using 
male MPN-MBH explants (Bonavera et al., 1998) and in vivo using microdialysis 
in steroid-primed females (Neal-Perry et al., 2005; Neal-Perry et al., 2008). Thus, 
beyond apparent changes to glutamate receptors themselves, there are 
accompanying changes in glutamate availability throughout the life cycle and it 
appears that these levels are regulated, at least in part, by the steroid hormone 
environment (Jarry et al., 1992; Carbone et al., 1995).  
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IV. SUMMARY 
The evidence for modulation of the reproductive axis by NMDARs 
throughout the lifespan is abundant. The goal of this dissertation is to further 
expand this literature to examine specifically the role of the NMDAR-NR2b 
subunit. I have discussed the evidence that the subunit composition of the 
NMDAR is vital to determining the channel properties of this receptor (Chen et 
al., 1999; Erreger et al., 2005) and that this changes both spatially and 
temporally in the nervous system (Sheng et al., 1994; Flint et al., 1997; Adams et 
al., 1999; Gore et al., 2000a; Kuehl-Kovarik et al., 2000; Magnusson, 2000; Gore 
et al., 2002; Miller and Gore, 2002). Additionally, studies specific to the 
hypothalamic level of the HPG axis have suggested that the NR2b subunit in 
particular is experiencing changes in both gene and protein expression (Gore et 
al., 2000a; Gore et al., 2002; Miller and Gore, 2002). Thus, my goal is to further 
determine anatomical changes in this receptor and to examine the functional 
implications of these changes in the aging female reproductive axis. In Chapter 
3, I examine the effects of administration of the NMDAR-NR2b selective 
antagonist ifenprodil to young and middle-aged rats on LH pulsatility in young 
and middle-aged female rats. In Chapter 4, I use this same drug to determine the 
role of the NR2b subunit in the estradiol-induced LH surge in middle-aged 
females undergoing reproductive senescence. Finally, in Chapter 5, I examine 
the NR2b population in the anteroventral periventricular nucleus, a hypothalamic 
nucleus important for female reproductive physiology, particularly the functional 
GnRH/LH surge and normal cyclicity (Wiegand et al., 1980). Together, these 
studies suggest a strong role for the NR2b subunit in the regulation of these 
female reproductive events, and suggest that this receptor subunit does indeed 
contribute to the onset of reproductive aging. 
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Chapter 2. General Methods 
This section contains a summary of the experimental methodology for the 
three experiments undertaken in this dissertation, as well as justification for these 
methodologies where appropriate. A more detailed methodology for each 
experiment can be found in subsequent chapters.  
 
I. JUSTIFICATION OF ANIMAL MODEL, AGES, AND HORMONE TREATMENTS 
A. Use of Sprague Dawley rats 
Sprague-Dawley rats are chosen as a model for the proposed 
experiments. The rat model is widely used for studying neural changes in 
reproductive function and has been used extensively for studies concerning 
development, puberty, and senescence in the Gore lab as well as many others 
(Wise, 1993; Becu-Villalobos and Libertun, 1995; Gore, 2001). The rat shows 
very clear signs of reproductive aging via changes to estrous cyclicity (refer to 
Figure 1.2), and, as it does not undergo follicular atresia, these changes are 
initiated via neuroendocrine regulation of the GnRH system (reviewed in (Rubin, 
2000; Maffucci and Gore, 2005)).  
 
B. Choice of animal ages/reproductive status 
Rats begin showing regular estrous cycles at approximately postnatal day 
(P) 32 (Steinberg et al., 2008) and continue these cycles through adulthood. As 
described in Chapter 1, the rodent estrous cycle is 4-5 days long and undergoes 
a transition to acyclicity between approximately 9.5 and 12 months of age (refer 
to Figure 1.2). Generally, by 12 months, the rat has achieved an acyclic state, in 
which cycling no longer occurs and the female is in a constant state of estrus 
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(called persistent estrus and accompanied by slightly elevated estrogen levels; 
Figure 1.2D) (Maffucci and Gore, 2005).  
During this time, reproductive hormones also undergo age-related 
changes. All rats exhibit a pulsatile pattern of gonadotropin-releasing hormone 
(GnRH) and luteinizing hormone (LH) release (Belchetz et al., 1978; Gallo, 1981; 
Steiner et al., 1982). However, the parameters of this release change with aging. 
Specifically, in middle-aged animals, LH pulse amplitude decreases and 
interpulse interval increases (Scarbrough and Wise, 1990). Further, the 
preovulatory GnRH/LH surge, necessary for ovulation, experiences a delay and 
attenuation during the middle-aged transition (Wise, 1984), with an eventual loss 
of this surge, and hence ovulation, in the acyclic animal (Huang et al., 1978; Lu 
et al., 1979) (refer to Figure 1.2). Thus, this time period is ideal to study for 
questions surrounding neuroendocrine changes during the transition to 
reproductive senescence.  
 
II. EXPERIMENT 1. THE NMDA RECEPTOR SUBUNIT NR2B: EFFECTS ON LH 
RELEASE AND GNRH GENE EXPRESSION IN YOUNG AND MIDDLE-AGED FEMALE 
RATS, WITH MODULATION BY ESTRADIOL  
A. Ages and hormone treatments 
Experiment 1 sought to determine effects of blockade of the NR2b subunit 
on pulsatile LH release. Rats were used at two ages: 3-5 months for young and 
10-12 months for middle-aged. In experiment 1, young (regularly cycling) and 
middle-aged (irregular or acyclic) animals were assigned to the study. 
Approximately 90% of our middle-aged animals were acyclic and the remaining 
10% were irregularly cycling. No statistical difference in effect was observed 
between these two groups and therefore data for all middle-aged rats were 
combined. As shown in Figure 2.1, rats were then ovariectomized, hormone 
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treated with estradiol or vehicle, and subjected to serial blood sampling. Thus, 
this study enabled us to dissect out effects of age (young vs. middle-aged) and 
hormone (estradiol vs. vehicle) on aspects of pulsatile LH release as affected by 
ifenprodil, the NR2b receptor antagonist. 
Previous studies show that estradiol affects NMDAR activation of GnRH 
neurons. In OVX, estradiol treated females, NMDAR agonists stimulate both 
GnRH release in vitro and LH release in vivo, whereas the absence of estradiol 
significantly reduces these effects (Arias et al., 1993). Further, administration of 
NMDAR antagonists prior to the estradiol-induced GnRH/LH surge inhibits this 
surge (Urbanski and Ojeda, 1990). These studies suggest estrogen-mediated 
regulation of NMDAR modulation of GnRH/LH activity. Thus, I was interested in 
how these previously determined interactions relate specifically to the NMDAR-
NR2b subunit. 
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Fig. 2.1: Experiment 1 design summary: NR2b and LH pulsatile release 
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B. Justification of ifenprodil tartrate 
Ifenprodil is a high affinity antagonist of NMDARs containing the NR2b 
subunit (Williams, 1993), and thus, is a useful drug for identifying contributions of 
the NR2b subunit in the regulation of the reproductive axis. It is a member of the 
phenylethanolamine family of allosteric NMDAR antagonists (Carter et al., 1988) 
(Figure 2.2). It is a non-competitive antagonist, thought to bind at a site located 
outside of the channel pore, and thus does not act as channel blocker (Reynolds 
and Miller, 1989; Legendre and Westbrook, 1991; Williams, 1993).  
 
Fig. 2.2: Chemical structure of ifenprodil tartrate. 
 
Figure 2.2: Chemical structure of ifenprodil tartrate.  
 
At physiologic pH (7.3-7.5), protons tonically inhibit approximately 50% of 
the NMDAR population (Tang et al., 1990; Traynelis and Cull-Candy, 1990; 
Traynelis et al., 1995). Changes to extracellular pH or modulation of this tonic 
inhibition via allosteric interactions on the receptor can lead to changes in this 
inhibition. Evidence suggests that ifenprodil activity is sensitive to pH (Pahk and 
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Williams, 1997), and further, that application of ifenprodil likely enhances the 
proton inhibition of these receptors (Mott et al., 1998). Thus, the main 
mechanism by which ifenprodil alters NMDAR function is believed to be via the 
proton sensor.  
In addition to this, ifenprodil shows a unique use-dependence. In the 
agonist-bound state, ifenprodil shows a higher binding affinity to NR2b-containing 
NMDARs, and hence a stronger inhibition of the receptor (Kew et al., 1996). 
Furthermore, at high concentrations, the presence of ifenprodil results in lower 
binding affinity for glycine (Legendre and Westbrook, 1991; Ransom, 1991; 
Williams, 1993). Thus, the concentration of available glutamate helps to 
determine the action of ifenprodil on the NMDAR. 
Ifenprodil is not entirely specific to the NR2b subunit of the NMDAR. In 
fact, it was originally developed as a vasodilator through its actions as an α1-
adrenergic receptor inhibitor (Adeagbo and Magbagbeola, 1985; Honda et al., 
1988). It has also been shown to interact with other receptors, specifically 
serotonin 5-hydroxytrytamine (5HT) receptors with a low affinity (Chenard et al., 
1991; McCool and Lovinger, 1995; Molderings et al., 1996), σ receptors 
(Contreras et al., 1990; Karbon et al., 1990) at nanomolar concentration in vitro, 
and voltage-gated Ca2+ channels (Church et al., 1994; Bath et al., 1996) and G 
protein-activated inwardly rectifying K+ channels (Koybayashi et al., 2005) at 
micromolar concentrations in vitro. Church et al. (1994) compared the effects of 
ifenprodil on both NMDAR and high voltage activated calcium channel blockade, 
found that the concentration of ifenprodil needed to block these calcium channels 
were 10x greater than that which was needed to antagonize NMDARs.  
In general, binding studies identified only NMDAR and σ sites as the 
target of ifenprodil (Karbon et al., 1990; Schoemaker et al., 1992). Grimwood et 
al. (2000) demonstrated that the dissociation constant of ifenprodil was 27.3 nM 
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and that this did not greatly differ when σ sites were blocked (KD = 24.8 nM), 
demonstrating that ifenprodil shows a very high affinity for NMDARs as 
compared to σ sites. In general, the literature suggests that the primary role of 
ifenprodil is as an NR2b selective antagonist. Its affinities for the remaining 
receptors are generally low and are attributed to clinical side-effects observed 
with adminsitration.  
Importantly, all of these other neurotransmitter systems (serotonin, 
adrenergic, calcium channels, potassium channels) are active in regulating the 
reproductive axis to some extent. Therefore, it can be argued that the 
mechanisms by which ifenprodil affects the LH response in the following 
reproductive axis experiments (chapters 3 and 4) may not be solely be due to 
actions on NMDARs; however, because of the strong affinity of ifenprodil for 
NR2b-containing NMDARs, it is likely due at least in part to this interaction  
Other NR2b selective antagonists are available for use and these are 
generally derivatives of ifenprodil. To date, ifenprodil is most often used for in 
vivo application and studies of physiological consequences of NR2b antagonism 
(Khan et al., 1999; Malinowska et al., 1999; Monassier et al., 1999; Rodrigues et 
al., 2001; De Vry and Jentzsch, 2003; Floyd et al., 2003). Other derivatives of 
ifenprodil include CP 101,606 and RO 25-6981. These drugs retain their high 
affinity for NR2b-containing NMDARs, with a higher selectivity for these 
receptors. CP 101,606 does not show the serotonergic antagonism and has a 
much lower affinity than ifenprodil for α1-adrenergic receptors (Chazot, 2004; 
Mott et al., 1998). This drug was not available for use at the time that these 
studies were performed. RO 25-6981 shows a weaker affinity for calcium channel 
blockade but retains the ability to inhibit the α1-adrenergic receptor, also to a 
lesser degree than ifenprodil (Pinard et al., 2001). Further, I performed a 
preliminary study comparing the effects of administration of ifenprodil or RO 25-
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6981 on LH pulsatility, and the results were similar: both drugs caused a 
comparable increase in LH pulse amplitude and LH release (data not shown). At 
the time that these dissertation experiments were performed, ifenprodil had been 
used in multiple physiological studies, including those in the central nervous 
system, whereas RO 25-6981 had not. This, in combination with my preliminary 
data showing similar effects of ifenprodil and RO 25-6981, led me to select 
ifenprodil for the purpose of this dissertation.  
 
III. EXPERIMENT 2. ANTAGONISM OF THE NMDA RECEPTOR SUBUNIT NR2B 
DISRUPTS THE ESTRADIOL-INDUCED LH SURGE IN MIDDLE-AGED FEMALE RATS 
Ages and hormone treatments: 
The second experiment sought to determine effects of ifenprodil on the 
steroid hormone-induced LH surge. In this study, only middle-aged animals were 
used, as it was previously established that ifenprodil affected LH release similarly 
in both young and middle-aged animals. Our interest was specifically in 
examining the repercussions of ifenprodil on the GnRH/LH surge, and to pursue 
differential effects of this drug on animals with differential prior reproductive 
history. Specifically, middle-aged rats were subdivided into those that were 
showing irregular estrous cycles prior to ovariectomy and those that were already 
in persistent estrus and were acyclic. Figure 2.3 shows the procedure for 
ovariectomy, hormone treatment, and blood sampling. In Experiment 2, all rats 
were given estradiol treatment, a requirement for the LH surge. Therefore, 
Experiment 2 was focused on the role of the NR2b subunit on the estradiol-
induced LH surge in middle-aged rats.  
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Fig. 2.3: Experiment 2 design summary: NR2b and the estradiol-induced LH 
surge 
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IV. EXPERIMENT 3. THE EXPRESSION OF THE NMDA RECEPTOR-NR2B SUBUNIT, 
AND ITS COLOCALIZATION WITH NR1, CHANGES AS A FUNCTION OF AGE AND 
ESTRADIOL TREATMENT IN THE AVPV OF THE FEMALE RAT 
A. Ages and hormone treatments 
The third experiment was designed to determine the anatomical site of 
action of glutamate acting through NR2b-containing NMDARs in the 
hypothalamus, and effects of age and steroid hormones. In this final experiment, 
three age groups were used, due to the availability of an older age group through 
a larger program project study in which all three age groups were examined. 
Thus, young, middle-aged, and old rats were assigned to this study (~4 months, 
12 months, and 23 months, respectively), which enabled us to examine animals 
of different reproductive status and chronological age. As in Experiments 1 and 
2, rats were given vaginal smears to ascertain reproductive cyclicity, then 
ovariectomized and given steroid hormone treatments.  
For Experiment 3, rats were assigned to one of three hormone groups 
(see Figure 2.4): vehicle + vehicle; estradiol + vehicle; and estradiol + 
progesterone. The ability to add in a progesterone-treated group was again 
afforded through the program project grant study, and enabled me to expand my 
analysis of effects of hormones to not just estradiol but also estradiol plus 
progesterone. Although estradiol alone is able to induce the GnRH/LH surge 
(Wise, 1984), the surge is amplified and its timing is consolidated by the addition 
of progesterone (Mahesh and Muldoon, 1987; Lee et al., 1990). Administration of 
a progesterone receptor antagonist (RU486) or epostane, a drug that inhibits 
progesterone synthesis, on the morning of proestrus results in an attenuation of 
the LH surge (Rao, 1986; DePaolo, 1988). Physiological levels of progesterone 
also undergo age-related changes. In the middle-aged, regularly cycling female 
rat, the expected rise of progesterone on the day of proestrus is reduced 
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compared to young rats (Wise, 1982).  Additionally, progesterone levels in 
acyclic animals decline (Lu et al., 1980), as do progesterone receptor populations 
in the hypothalamus (specifically the anteroventral periventricular nucleus, 
AVPV) (Mills et al., 2002). Finally, the normal sequence of hormone changes in 
the estrous cycle (refer to Figure 1.2) is first an increase in estradiol in late 
diestrus 2/early proestrus, followed by an increase in progesterone on estrus. 
This sequential timing is very important, as the increase in estradiol is necessary 
to induce hypothalamic progesterone receptors, on which the increased 
progesterone levels later in the cycle can act. These processes are attenuated 
with aging. Thus, the current study evaluated effects of sequential estradiol 
followed by progesterone, along with the previous treatments of vehicle or 
estradiol alone (Experiments 1 and 2). 
Progesterone also influences actions of NMDARs and glutamate release. 
Estradiol-priming, followed by progesterone, enhances the NMDAR-stimulated 
increase in GnRH release in vitro and LH in vivo in prepubertal female rats. In 
addition, it enhances glutamate release in the POA (Carbone et al., 1992; Ping et 
al., 1994b; Carbone et al., 1995; Moguilevsky et al., 1995). Accordingly, 
administration of NMDAR antagonists following estradiol-priming and 
progesterone administration inhibits the steroid-hormone induced LH surge 
(Brann and Mahesh, 1991a, b), as well as decreases the progesterone induced 
increase in GnRH mRNA levels in the POA-AH (Seong et al., 1993). Finally, 
blockade of progesterone leads to a decline in NR1 mRNA expression in the 
POA of adult, proestrus females at the time of the preovulatory LH surge (Brann 
et al., 2005). Thus, both progesterone and estradiol have regulatory effects on 
the NMDAR, and so provide interesting endpoints to examine when considering 
the role of the NMDAR and their interactions with steroid hormones, on age-
associated changes to this system.  
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Fig. 2.4: Experiment 3 design summary: Analysis of NR2b protein expression in 
the anteroventral periventricular nucleus 
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B. Choice of NMDAR subunit and AVPV region 
Previous studies from our lab have shown differential expression of 
various NMDAR subunits when comparing the young, middle-aged, and aged 
brain (Gore et al., 2000a; Gore et al., 2002; Chakraborty et al., 2003b). 
Specifically, a study of OVX, vehicle or estradiol treated females demonstrated a 
significant increase of NR2b mRNA expression in the POA-AH of aged animals 
compared to their young and middle-aged counterparts (Gore et al., 2002). 
Further, increases in NR1 and NR2a subunit mRNA expression were observed in 
intact aged females in this region (Gore et al., 2000a). Finally, 
immunohistochemical analysis of the NR1 subunit in the AVPV of the 
hypothalamus showed a decline in NR1 protein expression in aged animals 
compared to young (Chakraborty et al., 2003b). Thus, not only do the NMDAR 
subunits show alterations in expression in the middle-aged hypothalamus (Gore 
et al., 2000a; Miller and Gore, 2002; Chakraborty et al., 2003b), but also in the 
aged animals, suggesting both middle-aged and aged populations to be of 
interest for the development of an anatomical profile of NR2b expression in the 
AVPV in Experiment 3. 
Examination of the co-expression of estrogen receptors with NMDARs 
suggests a mechanism by which this regulation may occur. Chakraborty et al. 
(Chakraborty et al., 2003a) showed that a high percentage of cells expressing 
the NR1 subunit coexpress estrogen receptor alpha in both the AVPV and medial 
preoptic nucleus (MPN), two hypothalamic nuclei important for female 
reproductive physiology. Further, the presence of estradiol increases this 
coexpression. Thus activation of estrogen receptors in these regions important 
for regulation of reproductive function likely modulates the activity of NMDARs on 
the GnRH pathway, likely through altered expression of receptor subunits or 
responsiveness of the receptor itself to glutamate.  
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Chapter 3. The NMDA Receptor Subunit NR2b: Effects 
on LH Release and GnRH Gene Expression in Young 
and Middle-aged Female Rats, with Modulation by 
Estradiol 
 
ABSTRACT 
The loss of reproductive capacity during aging involves changes in the 
neural regulation of the hypothalamic gonadotropin-releasing hormone (GnRH) 
neurons controlling reproduction. This neuronal circuitry includes glutamatergic 
receptors on GnRH neurons. Previously, the Gore lab reported an increase in the 
expression of the NR2b subunit protein of the NMDA receptor on GnRH neurons 
in middle-aged compared to young female rats. Here, I examined the functional 
implications of the NR2b subunit on the onset of reproductive aging, using the 
NR2b-specific antagonist ifenprodil. Young (3-5 mos.) and middle-aged (10-13 
mos.) female rats were ovariectomized (OVX), 17β-estradiol (E2) or vehicle 
(cholesterol) treated, and implanted with a jugular catheter. Serial blood sampling 
was undertaken every 10 minutes for 4 hours, with ifenprodil (10mg/kg) or 
vehicle injected (i.p.) after one hour of baseline sampling. The pulsatile release of 
pituitary LH and levels of GnRH mRNA in hypothalamus were quantified as 
indices of the reproductive axis. Our results showed effects of ifenprodil on both 
endpoints. In OVX rats given cholesterol, neither age nor ifenprodil had any 
effects on LH release. In E2-treated rats, aging was associated with significant 
decreases in pulsatile LH release. Additionally, ifenprodil stimulated parameters 
of pulsatile LH release in both young and middle-aged animals. Ifenprodil had 
few effects on GnRH mRNA. Together, these findings support a role for the 
NR2b subunit of the NMDAR in GnRH/LH regulation. Because most of these 
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effects were exhibited on pituitary LH release in the absence of a concomitant 
change in GnRH gene expression, it is likely that NMDA receptors containing the 
NR2b subunit plays a role in GnRH-induced LH release, independent of de novo 
GnRH gene expression. 
 
INTRODUCTION 
Excitatory amino acids (EAAs) play a major regulatory role in the neuronal 
release of gonadotropin-releasing hormone (GnRH) from the hypothalamus, and 
subsequently luteinizing hormone (LH) from the pituitary gland, thereby affecting 
reproductive function. Glutamate is the most abundant EAA in the brain, and acts 
via both N-methyl-D-asparate (NMDA) and non-NMDA (AMPA and kainate) 
receptors to stimulate neuronal targets, including GnRH neurons (reviewed in 
(Mahesh and Brann, 2005)). NMDA and AMPA receptors have been co-localized 
on GnRH neurons (Gore et al., 1996; Miller and Gore, 2002; Bailey et al., 2006), 
and there is abundant evidence for the activation or inhibition of GnRH/LH 
release in response to NMDA and non-NMDAR agonists and antagonists, 
respectively, both in vitro and in vivo (Ondo et al., 1976; Arslan et al., 1988; 
Bourguignon et al., 1989b; Donoso et al., 1990; Brann and Mahesh, 1992; Arias 
et al., 1993; Ping et al., 1994a, 1995; Arias et al., 1996; Bonavera et al., 1998). 
This includes their involvement in the control of the pulsatile pattern of LH 
release (Arslan et al., 1988; Bourguignon et al., 1989b; Ping et al., 1994a, 1995), 
which is necessary for normal physiologic function (Belchetz et al., 1978; Gallo, 
1981; Steiner et al., 1982). Thus, glutamate receptors are part of the neural 
circuitry that regulates reproductive neuroendocrine function.  
During the transition to middle age, female rats exhibit a number of 
changes in their reproductive capacity, including a shift from a regular (4-5 day) 
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estrous cycle to an irregular (greater than 5 day) cycle and finally acyclicity 
(Mandl, 1961; Huang and Meites, 1975). During this period, a decline in LH 
levels (Huang et al., 1978), and changes in GnRH/LH pulsatile release, including 
decreases in LH amplitude and interpulse interval (Estes et al., 1980; Karpas et 
al., 1983; Scarbrough and Wise, 1990) can be detected. Additionally, the effect of 
age on GnRH gene expression is debated, as studies show increases, 
decreases and no change dependent upon the methodology used and 
hypothalamic nuclei assayed (reviewed in (Maffucci and A.C., 2005)). GnRH 
protein expression during this transition period also shows very little to no 
significant changes (Rubin and King, 1994; Funabashi and Kimura, 1995; Gore 
et al., 2000a; Miller and Gore, 2002). This suggests that the major change to the 
reproductive axis during this time is not to the expression of GnRH neurons, but 
rather its regulation by the neural circuitry influencing its actions. Numerous 
neurotransmitters and neurotrophic factors act on the GnRH neuron, both directly 
and indirectly. These are also undergoing age-related changes, and thus affect 
functional alterations in the hypothalamic control of reproduction. 
There is evidence that hypothalamic glutamate plays a role in these age-
associated changes, both through changes in glutamate release (Neal-Perry et 
al., 2005) and through altered responsiveness of NMDARs (Bonavera et al., 
1998) due to changes in glutamate’s interactions with NMDARs. The NMDAR-
stimulated release of mean LH seen in young rats is attenuated in middle-aged 
females (Arias et al., 1996) and aged (21-23 months) males (Bonavera et al., 
1998). To the authors’ knowledge, effects of NMDAR inhibition on LH release 
have not been reported in an aging rat model. However, administration of the 
NMDAR antagonist AP-5 to adult gonadectomized male (Arslan et al., 1988; Ping 
et al., 1995) or female (Ping et al., 1994a) rats results in a decline of LH pulse 
amplitude and mean levels in both males and females, as well as a decline of LH 
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pulse frequency and interpulse interval in females. Thus, I suggest that age-
associated changes in the expression or function of hypothalamic NMDARs 
contributes to alterations in GnRH/LH pulsatile release.  
Effects of glutamate agonists and antagonists on GnRH neurons are also 
modified by the steroid hormone environment. There is substantial co-expression 
of the NMDAR with estrogen receptors in the hypothalamus and preoptic area, 
suggesting that glutamate and estrogens may act on the same target cells to 
influence GnRH neurons (Chakraborty et al., 2003c; Chakraborty et al., 2003a). 
In most studies, effects of NMDAR activation on GnRH neurons are enhanced in 
the presence of estradiol (Arias et al., 1993; Gore, 2001; Gore et al., 2002).  
In the present study, I focused on the role of one NMDAR subunit, NR2b, 
in its age-related regulation of pulsatile LH release in female rats. The choice of 
the NR2b subunit was based upon previous evidence showing that this subunit 
specifically undergoes developmental and age-associated increases in its 
expression on GnRH neurons (Adams et al., 1999; Miller and Gore, 2002), and 
the NR2b gene is associated with a quantitative trait locus thought to be involved 
in the regulation of puberty in mice (Nathan et al., 2006). Along with their 
expression on GnRH cells, NMDARs are also abundantly expressed on non-
GnRH neurons in the hypothalamus, including regions that regulate GnRH 
release, and these also undergo age-related changes (Gore et al., 1996; Miller 
and Gore, 2002; Chakraborty et al., 2003c). Thus, effects of NMDAR activation 
on GnRH release involve both direct and indirect actions. Therefore, I used an 
NR2b selective antagonist, ifenprodil, to assess the role of the NR2b subunit on 
GnRH activity in the context of aging (young vs. middle-aged) and hormone 
environment (ovariectomy plus vehicle or 17β-estradiol).  
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METHODS 
Animals 
A total of 75 female Sprague-Dawley rats were used in this study, with 38 
young (3-5 mos.) and 36 middle-aged (10-12 mos.). All were purchased from The 
University of Texas at Austin Animal Resource Center rat colony (Austin, TX), 
which contains animals received and bred from Harlan Sprague-Dawley, Inc. 
(Indianapolis, IN). Animals were group housed (2-3/cage) in a temperature-
controlled room (21-22°C) with a 12-h light, 12-h dark reverse cycle (lights on at 
0100h). Food (standard rat chow) and water were provided ad libitum. All animal 
protocols were conducted in accordance with the Guide for the Care and Use of 
Laboratory Animals (National Research Council, 1996) following protocols 
approved by The University of Texas at Austin IACUC.  
 
Surgical Procedures 
The cycling status of all young and middle-aged animals was first 
determined through examination of daily vaginal cytology, observed for a 
minimum of 10 days. Rats were characterized as regularly cycling (4-5 day 
estrous cycles), irregularly cycling (6+ day estrous cycles) or acyclic (persistent 
estrus). Cycling animals were ovariectomized (OVX) at 1000 h on diestrus (for 
young, regularly cycling and middle-aged, irregularly cycling animals). Acyclic 
rats were OVX on persistent estrus (middle-aged, acyclic animals). Surgeries 
were performed under isoflurane gas anesthesia and rats were treated post-
operatively with 5 mg/kg Rimadyl. Four to six weeks later, animals were 
subcutaneously implanted at 1000 h with a Silastic capsule (capsule dimensions: 
inner diameter 1.96mm; outer diameter 3.18mm) containing either 5% 17β- 
estradiol/95% cholesterol (E2) or 100% cholesterol (Chol; Sigma-Aldrich, St. 
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Louis, MO) as vehicle, under isoflurane anesthesia (day 0). Young animals 
received an implant 1.0 cm in length; middle-aged animals received an implant 
1.5 cm in length. Different lengths were used to account for size differences 
associated with age differences (Adams et al., 2001b). Following surgery, 
animals were housed individually. Two days following hormone replacement (day 
2), animals were implanted with a jugular catheter (modified from (Duvauchelle et 
al., 1998)). Rats were anesthetized with ketamine (90 mg/kg, i.p.) and xylazine 
(10 mg/kg, i.p.). A Silastic catheter (0.51 mm inner diameter, 0.94 mm outer 
diameter) was inserted into the right jugular vein and advanced into the right 
atrium. A cannula (Plastics One, Roanoke, Virginia), located at the distal end of 
the catheter, was subcutaneously routed around the neck and out through an 
incision on the top of the head. Here, it was affixed to the skull with stainless 
steel screws and dental acrylic cement. Catheters were flushed daily and 
patency verified using 0.1 ml or 30 U/mL heparinized saline, 62 mg/mL Timentin. 
In cases where the jugular catheter did not remain patent through serial blood 
sampling, animals were given a new catheter in the left jugular vein (day 4) and 
serial blood draws were resumed on day 6. There was no effect of this process 
on any results. 
 
Serial Blood Sampling 
On day 4, from 1000 to 1400h, animals were placed in aquaria divided into 
two chambers with no visual or tactile contact. Catheters were attached to St. 
Gobain tubing (inner diameter 0.508 mm; outer diameter 1.524 mm; VWR 
#63018-044), attached to a 22G needle with a 3cc syringe filled with 5U/mL 
heparinized saline. Syringes were suspended from the top of the aquaria, 
allowing the animals to move freely during serial blood sampling. 0.2 cc of blood 
was collected into heparinized microcentrifuge tubes (1000 U/mL) every 10-
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minutes for four hours. Following each collection, bloods were centrifuged at 600 
x g for 5 minutes. Serum was collected and stored on ice. The remaining red 
blood cells were resuspended in an equal volume of 5U/mL of heparinized saline 
and reinfused into the animal in order to maintain hematocrit levels. 
 
Drug administration 
Animals were administered either vehicle (0.1% tartaric acid) or ifenprodil 
tartrate (10 mg/kg BW; ddH2O; Sigma-Aldrich, St. Louis, MO) intraperitoneal (i.p.) 
following one hour of serial blood sampling. This dose was chosen based on 
previous in vivo experiments, showing it to be effective for i.p. injections in both 
mice and rats (Narita et al., 2000; Rodrigues et al., 2001), and preliminary data 
from our lab. Narita et al. (Narita et al., 2000) used a 10 mg/kg i.p. dose in mice 
to demonstrate the involvement of the NR2b subunit in ethanol withdrawal, and 
further showed a change in the NR2b subunit limbic forebrain population 
following treatment. Furthermore, Rodrigues et al. (Rodrigues et al., 2001) used 
varying concentrations of ifenprodil (1.0 mg/kg, 3.0 mg/kg and 10.0 mg/kg) to 
demonstrate a dose-dependent inhibition of fear acquisition in rats, with 10 mg/kg 
showing the strongest effects. This result was then duplicated with an intra-
amygdala application of the drug. Preliminary experiments in our lab examined 
the effects of both 1 mg/kg and 10 mg/kg doses on LH levels in female rats, and 
found the 10 mg/kg dose to be most effective. Together, these studies support 
the efficacy of the 10 mg/kg dose in the rat model, without causing toxicity. A 
higher dose was not attempted due to concerns of toxicity.  
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Collection of hypothalamic tissue and trunk blood 
Following serial blood samples (4 hours) animals were humanely 
euthanized by decapitation. Trunk bloods were collected, allowed to clot, and 
centrifuged at 6000 x g. Serum was stored at -80°C for later LH and estrogen 
radioimmunoassay. Brains were removed and the preoptic area-anterior 
hypothalamus (POA-AH) was dissected, as described previously (Jakubowski 
and Roberts, 1992). Briefly, dissections were done using a cold, stainless steel 
brain matrix, flash-frozen on dry ice, and stored at -80°C.  
 
RNA Extraction for Real-Time PCR 
RNA was extracted from frozen POA-AH tissues using a well-established 
in house double detergent lysis buffer system, adapted from Jakubowski and 
Roberts (Jakubowski and Roberts, 1992). Briefly, tissues were homogenized via 
extrusion through a 22-gauge needle, treated with proteinase K, and RNA was 
extracted in phenol chloroform and precipitated in ethanol. Nuclear and 
cytoplasmic portions were separated using a two buffer system. The cytoplasmic 
RNA of each animal was treated with DNase Free kit (Ambion, Austin TX) 
according to manufacturer’s specification. RNA integrity was confirmed using a 
bioanalyzer (Agilent 2100) and concentration determined using Nanodrop ND-
1000. RNA was then stored at -80 until use in real-time PCR.  
 
Real Time PCR 
GnRH gene expression was determined in the POA-AH and normalized to 
a housekeeping gene, cyclophilin (Gore and Roberts, 1994; Medhurst et al., 
2000). A reverse transcriptase reaction was carried out using 2 µg of cytoplasmic 
RNA with Superscript II Reverse Transcriptase (Invitrogen, Carlsbad CA), 
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according to the manufacturer’s instructions. Product was stored at –20°C until 
use, at which time, cDNA was diluted 1:5 before PCR reactions were performed. 
Real-time PCR was performed using the Stratagene Brilliant® qPCR 
master mix and were run on a Stratagene MX3000 (Stratagene La Jolla, CA) 
using the following reaction parameters: 1 cycle at (95°C for 10 minutes followed 
by 45 cycles at 95°C for 30 seconds, 55°C for 1 minute, and 72°C for 30 
seconds. All reactions were run using primer and probe sequences developed 
and tested in house (GnRH) or previously published (cyclophilin; (Medhurst et al., 
2000) (IDT, Coralville IA primers; Eurogentec) at concentrations listed in Table 1. 
A validation experiment was performed for the GnRH and cyclophilin assays to 
ensure that the reaction efficiencies were comparable. Each product was run on 
a 3% agarose gel to confirm amplicon length and specificity. A no reverse 
transcriptase (no RT) control was run for each sample to determine if genomic 
contamination was present. Any samples containing significant contamination 
were discarded from analysis (Ct < 10). A positive control was run on each plate 
to determine interassay variability. 
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Table 3.1: Cyclophilin and GnRH primer and probe sequences for real-time PCR 
reaction. 
* Previously published sequences (Medhurst et al., 2000); ** Designed using PrimerExpress 
Relative expression of GnRH mRNA levels, normalized to cyclophilin 
mRNA levels and calibrated with a positive control, was determined using the 
delta delta Ct method (Pfaffl, 2001). Samples were run in triplicate and analyzed 
in duplicate to account for pipetting errors. Interassay variability was 9.0%.  
 
Radioimmunoassay (RIA) 
LH: LH in serum samples was determined in single samples using double 
antibody RIA. This RIA was performed using the rat LH RP-3 standard, iodinate 
and antibody from the National Hormone and Pituitary Program of the NIDDK 
(kindly provided by Dr. A.F. Parlow). Three assays were performed. The assay 
sensitivity was 0.03 ng/tube at 85% binding. The intraassay variability ranged 
from 3.6-12.3%. Interassay variability was 2.95%. 
  
Estradiol: E2 levels were determined in serum samples from trunk bloods when 
there was residual serum from the LH assay. The DSL ultrasensitive estradiol 
DSL kit (DSL-4800, Diagnostic Systems Laboratories, Inc., Webster, TX) was 
Gene Forward 
Primer  
(5’ – 3’) 
Reverse 
Primer 
(3’ – 5’) 
Probe 
(Taqman only) 
[Primer] (nM) 
[Probe] (nM) 
*Rat 
cyclophilin  
5’- TGT GCC 
AGG GTG 
GTG ACT T -
3’ 
5’- TCA AAT 
TTC TCT CCG 
TAG ATG 
GAC TT -3’ 
5’- CCA CCA 
GTG CCA 
TTA TGG 
CGT GT –3’ 
F: 300 R: 300 
Probe: 150 
**Rat 
GnRH 
5’- CCC TTT 
GGC TTT 
CAC ATC CA 
–3’ 
5’- AAC AGC 
GGC CAT 
CAG TTT G –
3’ 
5'- ACA GAA 
TGG AAA 
CGA TCC 
F: 900 R: 900 
Probe: 300 
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used according to the included instructions. Samples were run in duplicate in a 
single assay. The intraassay variability was 2.8%. 
 
Statistical Analysis 
 
Pulse analysis: A computer based pulse detection method, Cluster, was used to 
analyze pulsatile release of LH (Velduis and Johnson, 1986). This is available in 
the Pulse_XP software suite provided by Michael L. Johnston (University of 
Virginia, VA). This algorithm identifies significant increases and decreases within 
a data set in relation to measurement error inclusive to experimental data. A 
moving nadir (referred to as a test nadir and defined as a cluster of points) of two 
points for test nadir were compared to two experimental points using pooled t-
test to determine significant rises within the data set. The entire data set is 
examined for increases in significance through shifting of test nadir and 
experimental points by one sample. This continues through the entire series, and 
upon completion, the process moves in reverse to determine significant falls in 
the data. A peak is defined as a significant increase followed by a significant 
decrease, and thus a peak must be surrounded by nadirs on each side.  
In this analysis, we used parameters suggested by the program 
developers. In brief, this includes 2 points used to define peaks and nadirs, a t 
statistic of 2.75 for significant increases and 1.5 for significant decreases, and 
two degrees of freedom for sample mean (Velduis and Johnson, 1986). Analyses 
include mean LH (average LH value for the entire experimental period from the 
second to the penultimate sample (see below)), pulse frequency (number of 
peaks) and amplitude (height of peaks), pulse width (in minutes) and area 
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(defined as the product of the mean peak subtracted from the average of the pre- 
and post-peak nadirs multiplied by the peak width), interpeak intervals (between 
peak regions) and interpeak concentrations (Velduis and Johnson, 1986). 
Significant changes in these variables were determined using one-way and two-
way analysis of variance (ANOVA) and the Kruskal-Wallis non-parametric test, 
when normality assumptions were violated. The effects of age and drug, as well 
as their interactions, were tested. Post-hoc analyses were performed when a 
significant main effect was detected. An effect was considered significant at p < 
0.05. 
Raw data was rescaled to fit all points within the same range. Any animals 
with one or more data point reaching minimal or maximal detectability of the LH 
RIA assay were excluded based on recommendations from a biostatistician, Dr. 
W.Y. Wendy Lou. Thus, the numbers of animals shown in the Results differ from 
the initial numbers of animals assigned to this study. The final n’s used for 
analysis are presented in the figure legends. The initial data point for each data 
set was dropped to limit effects of stress on LH levels during the initiation of 
serial blood sampling, and the final data point was excluded from analysis 
because it was collected at the time of terminal decapitation. Finally, no 
differences were observed in irregularly cycling middle-aged animals (N=25) 
when compared to those in persistent estrus (N=8), so these groups were 
combined.  
 
GnRH mRNA analysis: GnRH mRNA levels were normalized to the 
housekeeping gene cyclophilin in each animal. All results are expressed as the 
 53 
mean ± SEM. ANOVA was performed by the Statview 5.0 program for Macintosh 
computer to ascertain differences between groups. Results were considered 
significant at p < 0.05.  
 
RESULTS   
Effects of ifenprodil on LH release in young and middle-aged female rats 
The LH profiles for one representative animal from each group of 
cholesterol and 17β-E2 treated animals are shown in Figures 1 and 2 
respectively. Rats had detectable pulses of LH in all treatment groups. As 
expected, serum LH levels were high in OVX, cholesterol-treated young and 
middle-aged rats (Figure 3.1) and were low in OVX, E2-treated rats due to 
negative feedback of E2 on GnRH and LH (Figure 3.2).  
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Fig 3.1: Representative examples of LH pulsatile release from OVX young and 
middle-aged female rats 
 
Figure 3.1: Individual profiles of pulsatile LH release, measured in serum samples collected every 
10 minutes in representative young (A, B) and middle-aged (C, D) OVX, cholesterol replaced 
female rats. Please note that the x-axis scales vary among treatment groups to better 
demonstrate individual pulses. Animals were injected with vehicle or ifenprodil (10 mg/kg) one 
hour after blood sampling began. Arrows indicate the time point immediately preceding the 
injection. Asterisks (*) indicate significant pulses as indicated by the Cluster pulse detection 
software. Chol = cholesterol.  
Maffucci et. al., 2008 
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Fig 3.2: Representative examples of LH pulsatile release in OVX, estradiol-
treated young and middle-aged female rats 
 
Figure 3.2: Individual profiles of pulsatile LH release, measured in serum samples collected every 
10 minutes in representative young (A, B) and middle-aged (C, D) OVX, 17β-estradiol replaced 
female rats. Please note that the x-axis scales vary among treatment groups to better 
demonstrate individual pulses. Animals were injected with vehicle or ifenprodil (10 mg/kg) one 
hour after blood sampling began. Arrows indicate the time point immediately preceding the 
injection. Asterisks (*) indicate significant pulses as indicated by the Cluster pulse detection 
software. E2 = 17β estradiol.  
Maffucci et al., 2008 
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Cholesterol treated animals:  
The selective NR2b antagonist, ifenprodil, had no effect on the parameters 
of total and pulsatile LH release, including area under the LH curve (Fig. 3.3A), 
area under the peak (Fig. 3.3B), mean LH release (Fig. 3.3C), or LH peak 
amplitude (Fig. 3.3D). In addition, in OVX, cholesterol-treated rats, none of these 
parameters differed between young and middle-aged rats. In this group, as well 
as in the estradiol animals described below, the following parameters were not 
significantly affected by ifenprodil: pulse frequency, pulse width, interpeak 
intervals, and interpeak concentrations (data not shown). 
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Fig 3.3: Effect of ifenprodil on parameters of LH pulsatile release in OVX young 
and middle-aged females 
 
Figure 3.3: Parameters of pulsatile LH release were determined in young and middle-aged female 
rats that were OVX and treated with cholesterol. Group data (mean + SEM) are shown for area 
under the LH concentration curve (A), area under the LH peak (B), mean LH (C), and LH peak 
amplitude (D). There were neither any significant effects of age (young vs. middle-aged) nor drug 
treatment (ifenprodil vs. vehicle) on any parameters of LH release. N=3, 7, 4, and 8 for young 
vehicle, young ifenprodil, middle-aged vehicle, middle-aged ifenprodil, respectively. Chol = 
cholesterol; Veh = vehicle; Ifen = ifenprodil; AUC = area under the curve; AUP = area under the 
peak. 
Maffucci et al., 2008 
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17β-Estradiol-treated animals:  
In contrast to the cholesterol group, there was both an age and drug effect 
observed for serum LH levels. Post-hoc analyses showed that middle-aged E2-
treated animals had significantly lower levels of LH as compared to young 
animals in the measurements of area under the LH curve (Fig 3.4A; p < 0.003), 
area under the peak (Fig. 3.4B, p = 0.0346), mean LH (Fig. 3.4C; p = 0.001), and 
peak amplitude (Fig. 3.4D; p = 0.0039). Additionally, administration of ifenprodil 
caused increases in three of these parameters: area under the LH curve (Fig. 
3.4A; p = 0.0151), mean LH (Fig. 3.4C; p = 0.014), and peak amplitude (Fig. 
3.4D; p = 0.0134), but not area under the peak. 
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Fig 3.4: Effect of ifenprodil on parameters of LH pulsatile release in OVX, 
estradiol-treated young and middle-aged females 
  
Figure 3.4: Parameters of pulsatile LH release were determined in young and middle-aged 
female rats that were OVX and treated with estradiol. There was a significant decline with age in 
area under the LH concentration curve (A), area under the peak (B), mean LH (C) and LH peak 
amplitude (D). Ifenprodil administration resulted in a significant increase in area under the curve, 
mean LH, and LH peak amplitude in both young and middle-aged OVX, estradiol-treated rats. All 
data shown are mean + SEM. N=10, 4, 5, and 5 for young vehicle, young ifenprodil, middle-aged 
vehicle, and middle-aged ifenprodil, respectively. *, p < 0.05 vs. comparable drug or age group; 
**, p < 0.01 vs. comparable drug or age group. E2 = estradiol; Veh = vehicle; Ifen = ifenprodil; 
AUC = area under the curve; AUP = area under the peak. 
Maffucci et al., 2008 
Effects of Ifenprodil on GnRH mRNA expression in the POA-AH of young 
and middle-aged female rats 
No effects of either age or hormone on GnRH mRNA levels were 
observed, as these were similar in cholesterol and E2-treated rats, as well as 
young and middle-aged rats (Fig. 3.5). The only significant difference detected 
was for drug (ifenprodil vs. vehicle) in the middle-aged, cholesterol-
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In this group, GnRH mRNA levels were modestly but significantly lower in 
ifenprodil-treated rats (p < 0.05) as compared to their vehicle treated 
counterparts. 
 
Fig 3.5: Effect of ifenprodil on GnRH mRNA levels in young and middle-aged 
female rats 
  
Figure 3.5: GnRH mRNA levels in the preoptic area-anterior hypothalamus, normalized to 
cyclophilin mRNA, were quantified by real-time PCR. Data are shown for the OVX cholesterol (A) 
and estradiol-treated (B) rats. No overall effect of age or drug treatment was detected, although a 
significant interaction of age x treatment was detected, which was attributable to the OVX, 
cholesterol-treated middle-aged group, in which ifenprodil caused a small but significant decrease 
in GnRH mRNA levels. *, p < 0.05. Veh = vehicle, Ifen = ifenprodil. For panel A (cholesterol rats), 
N=6, 6, 8 and 8 for young vehicle, young ifenprodil, middle-aged vehicle, and middle-aged 
ifenprodil, respectively. For panel B (estradiol rats), N=8, 5, 6 and 8 for the same respective 
groups. 
Maffucci et al., 2008 
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17β-Estradiol levels in young and middle-aged, ovariectomized female rats 
The average E2 levels for OVX young and middle-aged, cholesterol-
treated rats were 1.01 ± 0.14 pg/ml and 0.76 ± 0.26 pg/ml, respectively. The 
average E2 levels for OVX, E2-treated young and middle-aged rats were 332 ± 
102 pg/ml and 314 ± 51 pg/ml, respectively. Although levels of estradiol were 
higher than anticipated and were often supraphysiological, each treatment group 
included animals with levels ranging from the physiological to the 
supraphysiological range, and there were no differences in results from animals 
across this range of estradiol levels. The results also showed comparable levels 
of E2 in the young and middle-aged rats. 
 
DISCUSSION 
The present results add to the mounting evidence for the regulation of the 
neuroendocrine hypothalamus by glutamate, showing for the first time a 
functional role for the NR2b subunit of the NMDAR. Here, I used the NR2b-
selective antagonist ifenprodil and measured its effects on serum LH levels as a 
proxy for GnRH release, which cannot be measured in the general circulation. 
However, actions of NMDAR agonists/antagonists on pituitary LH release are 
mediated exclusively through hypothalamic GnRH neurons (Donoso et al., 1990; 
Arias et al., 1993; Luderer et al., 1993; Arias et al., 1996; Bonavera et al., 1998; 
Claypool et al., 2000; Mahesh and Brann, 2005), and therefore, any effects of 
ifenprodil on LH release likely represent its effects on hypothalamic GnRH 
release. Our current results show that treatment with ifenprodil results in 
significantly higher levels of pulsatile LH than vehicle controls. Both young and 
middle-aged rats were responsive to ifenprodil, and this effect was limited to rats 
given estradiol (but not cholesterol) treatment, suggesting that the steroid 
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environment modifies effects of NMDAR-acting drugs on GnRH output. The 
implications of these findings, as discussed in greater detail below, are that the 
subunit composition of the NMDAR plays a role in its function in the reproductive 
neuroendocrine system.  
 
NMDAR regulation of GnRH neurons: Role of the NR2b subunit  
Previous studies have shown that at the dose used in the current study, 
ifenprodil is a selective antagonist for NMDARs containing the NR2b subunit 
(Williams, 1993, 2001), crosses the blood brain barrier (Benavides et al., 1992; 
Grimwood et al., 2000), and exerts actions in the central nervous system for at 
least 2 hours (Grimwood et al., 2000) and up to 12 hours post-application (Narita 
et al., 2000). Here, ifenprodil injection enhanced pulsatile LH release in young 
and middle-aged OVX, estradiol-treated rats. This finding suggests that the 
presence of the NR2b subunit in NMDARs affecting GnRH neurons decreases 
their responsiveness to endogenous glutamate. This result may be explained by 
the stoichiometry and properties of the NMDAR, which is a heteromeric complex 
composed of an NR1 subunit, necessary for channel function, co-assembled with 
one or more types of NR2 (a-d) or NR3 (a, b) subunits. The subunit composition 
of the NMDAR alters its properties, influencing channel kinetics, intracellular 
responses, and ligand affinities (Schoepfer et al., 1994). NR1, NR2a, and NR2b 
are the most abundant subunits expressed in the hypothalamus (Meeker et al., 
1994; Eyigor and Jennes, 1997; Herman et al., 2000) and all are co-expressed 
by GnRH cell bodies and nerve terminals (Kawakami et al., 1998b; Gore et al., 
2000a; Gore, 2001; Miller and Gore, 2002). Of these, only the NR2b subunit has 
been found to show age-associated changes specifically on GnRH neurons, 
increasing its co-expression in the preoptic area-anterior hypothalamus (POA-
AH), an area rich in GnRH perikarya, of middle-aged females as compared to 
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their young counterparts (Miller and Gore, 2002). A previous report indicated that 
the presence of the NR2b subunit in the NMDAR complex is associated with a 
decreased probability of channel opening, increased deactivation time, and 
slower recovery from desensitization when compared to NR2a (Vicini et al., 
1998). Thus, it is our belief that the previously demonstrated age-related increase 
in NR2b co-expression on the GnRH neurons of the POA-AH, and hence an 
increase in the ratio of NR2b to NR2a containing receptors, causes delayed and 
decreased channel opening, resulting in an alteration in the NMDAR stimulation 
of GnRH release. Our current results showing an enhancement of pulsatile LH 
release by ifenprodil, which selectively blocks receptors containing NR2b but 
would enable activity of NMDARs that do not contain NR2b, is consistent with 
this hypothesis.  
In the present study, I observed a significant increase in area under the 
LH curve, mean LH, and LH pulse amplitude following ifenprodil treatment in both 
age groups of estradiol-treated OVX rats. I interpret this to mean that blockade of 
NMDARs containing the NR2b subunit allows other (non-NR2b containing) 
NMDARs to mediate effects of glutamate, resulting in either an increase in the 
number of GnRH neurons firing or the amount of peptide being released during 
individual neuronal firing. This is further supported by the observed increase in 
mean LH and area under the LH curve. Furthermore, the lack of significant 
change of LH area under the peak suggests that ifenprodil is acting to increase 
baseline levels of LH, rather than simply increase the concentration released 
during each pulse.  
I was surprised that OVX, estradiol-treated rats of both age groups 
responded in a similar way to ifenprodil. However, both age groups have NR2b-
containing NMDARs, albeit at differing levels (Gore et al., 2000a; Miller and 
Gore, 2002), and both received a treatment that altered the NMDAR population. 
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Ifenprodil binds only to NMDARs containing the NR2b subunit, and its 
effectiveness at inhibiting these channels is determined by the receptor 
stoichiometry, specifically, the number of NR2b subunits encompassed within the 
channel (Hatton and Paoletti, 2005). Moreover, as discussed below, not only 
does ifenprodil act upon GnRH neurons, but it also exerts effects on afferents to 
this system that may also possess NMDARs with NR2b subunits. Thus, the 
heterogeneous nature of this receptor, as well as the multiple mechanisms by 
which it may exert influence on the reproductive axis (both directly and indirectly) 
suggests that ifenprodil may exert broad effects on this hypothalamic neural 
circuitry regulating GnRH. This intimates why both young and middle aged rats 
are responsive to ifenprodil, as it may be through different populations of 
NMDARs, but warrants further investigations to tease apart these mechanisms. 
It seems counterintuitive that blockade of receptors for an excitatory amino 
acid such as glutamate may result in an up-regulation of pulsatile LH release. I 
feel that the most reasonable explanation is that the effects of ifenprodil are 
occurring not only on GnRH neurons themselves, but also on neurons that make 
direct and indirect inputs to GnRH cells. For example, GABA-containing neurons, 
the principal inhibitory neurotransmitter in the brain and the counterpart to 
glutamate’s role as the principal excitatory neurotransmitter, inhibit GnRH release 
(Leranth et al., 1985; Petersen et al., 1993). If this GABAergic inhibition is 
stimulated by glutamate, the removal of glutamatergic input by ifenprodil to these 
GABAergic neurons would disinhibit GnRH neurons, thereby facilitating GnRH 
release. It is even possible that the same neurons co-express glutamate and 
GABA and that the balance of their outputs affect GnRH release, as postulated 
by Ottem et al. (Ottem et al., 2004). Moreover, there are age-alterations in 
hypothalamic-preoptic GABA release and biosynthesis in rats (Grove-Strawser et 
al., 2007). Thus, the balance of glutamate and GABA regulation of GnRH 
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neurons, directly and/or indirectly, may play important roles in neuroendocrine 
regulation. 
 
Estradiol-NMDAR interactions 
Ifenprodil enhanced pulsatile LH release only in OVX rats treated with 
estradiol, but not cholesterol treated OVX rats. These findings are consistent with 
previous evidence for an enhanced sensitivity of the GnRH neurosecretory 
system to NMDAR agonists or antagonists in the presence of estrogens (Arias et 
al., 1993; Jiang et al., 1997; Miller and Gore, 2002). For example, pulsatile LH 
release in adult female OVX rats was enhanced by NMDA in E2- but not vehicle-
treated animals (Arias et al., 1993). Similarly, MK-801, a competitive NMDAR 
antagonist, affected pulsatile LH release only in E2- but not vehicle-treated sheep 
(Jiang et al., 1997). The site of convergence of estrogens and glutamate is still 
unknown, but in the case of GnRH release, it is likely to occur via inputs to the 
GnRH system rather than in GnRH neurons themselves (Wintermantel et al., 
2006). Importantly, estrogen receptor alpha (ERα) and NMDARs are co-
expressed in cells in regions of the hypothalamus and preoptic area that regulate 
GnRH neurons (Chakraborty et al., 2003a), suggesting an anatomical site at 
which endogenous glutamate and estrogens can interact upon the same target 
cells to enhance the sensitivity of the GnRH system. Alternatively, or in addition, I 
cannot exclude the possibility that an enhanced pituitary responsiveness to 
GnRH in the presence of estradiol may amplify effects of ifenprodil on the GnRH 
system. Taken together, this evidence suggests that NMDAR antagonists may 
require modulation by estrogen in order to affect pulsatile LH release, a 
conclusion that is consistent with the results of this study showing stimulatory 
effects of ifenprodil only in estradiol-treated rats.  
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Effects of ifenprodil on LH release occur independently of effects on GnRH 
gene expression  
Overall, robust effects of ifenprodil on GnRH mRNA levels, an index of 
GnRH gene expression, were not detected. Only the middle-aged, OVX rats that 
were cholesterol (but not estradiol) treated had decreased GnRH mRNA levels 
following ifenprodil compared to its vehicle control. This change, while significant, 
was not large in magnitude, and it is notable that this same group of rats did not 
respond to ifenprodil with a significant change in pulsatile LH release. This 
finding, together with our observations that ifenprodil significantly increases 
pulsatile LH release in the estradiol-treated young and middle-aged rats, 
suggests an uncoupling of GnRH biosynthesis and GnRH release. Therefore, the 
majority of the effects of ifenprodil probably occur on the secretory pool of GnRH 
vesicles that stimulate LH pulses from the pituitary gland, without causing 
changes in GnRH biosynthesis, at least at the time points measured. There are 
several alternative or complementary explanations. It is possible that changes in 
GnRH mRNA may occur more rapidly (e.g., within 15 minutes to 1 hour), similar 
to what has been reported for effects of N-methyl-D,L-aspartate (NMA) (Petersen 
et al., 1991; Gore and Roberts, 1994), whereas in the current study, rats were 
euthanized four hours after ifenprodil injection. Alternatively, GnRH mRNA may 
replenish pools of the GnRH peptides over a longer time course. Future studies 
evaluating the time course of effects of ifenprodil on GnRH gene expression will 
enable us to detect whether this is a target for effects of NR2b antagonism. The 
concept that NMDAR agonists and antagonists may exert differential effects on 
GnRH cell bodies (as manifested by changes in gene expression) and on GnRH 
nerve terminals (as manifested by GnRH release) is one that the Gore lab has 
posited previously (Yin and Gore, 2006) and is consistent with reports that not 
only do GnRH cell bodies co-express NMDAR subunits (Miller and Gore, 2002), 
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but that GnRH nerve terminals express NMDAR subunits (Kawakami et al., 
1998a; Kawakami et al., 1998b; Yin et al., 2007) and may be a direct site of 
regulation by glutamate, independent of activity on GnRH perikarya. 
Previous studies show that administration of NMDAR agonists stimulate 
GnRH gene expression, and that this effect is dependent upon reproductive 
status, age, sex, hormonal status, and the time points observed following 
administration (Liaw and Barraclough, 1993; Gore and Roberts, 1994; Ottem et 
al., 2002). There is much less information as to the effect of NMDAR antagonists 
on GnRH gene expression. Seong et al. (Seong et al., 1993) found 
administration of the NMDAR antagonist MK-801 to OVX, estrogen and 
progesterone treated adult female rats caused a decrease in GnRH gene 
expression in hypothalamic fragments. However, Ottem et al. (Ottem et al., 2002) 
found that while estrogen induced an increase in GnRH gene expression in 
lateral and medial POA when comparing expression at two different time points 
(0600h and 1200h on diestrus 2), MK-801 was not effective in inhibiting this 
increase. Our results showed no effect of ifenprodil on GnRH gene expression in 
estradiol-treated OVX rats. These data reinforce the sensitivity of this system, in 
that particular time points, cycle periods, and hormonal environments together 
determine GnRH gene expression. Nevertheless, I showed that in the absence of 
steroid treatment, gene expression was decreased by ifenprodil in middle-aged 
animals only.  
 
CONCLUSION 
Overall, this study provides further evidence that the subunit composition 
of the NMDAR, and specifically the NR2b subunit, contributes to the regulation of 
GnRH/LH release in the female hypothalamus. Blockade of NMDAR-NR2b in the 
presence of estradiol has a stimulatory effect on GnRH neurons, resulting in 
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increased pulsatile LH output. Although pulsatile release of LH was similarly 
affected by ifenprodil in the two age groups, GnRH mRNA expression was 
selectively decreased only in one group, the cholesterol-treated middle-aged 
rats. These results suggest a dissociation of effects of glutamate, acting through 
NMDA receptors containing the NR2b subunit, on pulsatile GnRH release and 
GnRH gene expression 
.  
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Chapter 4. Antagonism of the NMDA receptor subunit 
NR2b disrupts the estradiol-induced LH surge in middle-
aged female  
  
ABSTRACT 
The hypothalamo-pituitary gonadal (HPG) axis has multiple levels of 
regulation, including a complex network of neuromodulators at the level of the 
hypothalamus that regulates gonadotropin-releasing hormone (GnRH) release. 
During the transition to reproductive aging, this network affects changes on the 
HPG axis that contributes to the loss of reproductive capacity. Among these 
neuromodulators is the excitatory amino acid, glutamate. Previously, the Gore 
lab reported that middle-aged female rats undergo changes in mRNA and protein 
levels of the NMDAR-NR2b subunit in the hypothalamus as compared to young 
rats. Further, the pulsatile release of LH is augmented in response to an NR2b 
selective antagonist, ifenprodil (see chapter 3). In the present study, I sought to 
determine the effects of selective NR2b subunit antagonism on the LH surge in 
ovariectomized (OVX), estradiol treated, middle-aged females. Rats were 
monitored by vaginal smears to determine estrous status, and categorized as 
having irregular estrous cycles (6+ days) or acyclic (persistent estrus). Then, rats 
were OVX and allowed to recover for four weeks. At that time, animals were 
primed with estradiol via a subcutaneous Silastic capsule, and implanted with a 
jugular catheter. Three to four days later, serum was collected every hour for 10 
hours, with either ifenprodil (10 mg/kg) or vehicle (0.9% tartaric acid) 
administered following the 2nd hour of sampling. Vehicle-treated, irregularly 
cycling animals showed an expected LH surge, whereas ifenprodil treated 
animals showed an acceleration in this surge. Acyclic animals in both treatment 
 70 
groups showed no LH surge, and no effect of drug. This study offers preliminary 
data supporting a role for the NR2b subunit in the regulation of the LH surge 
during the transition to acyclicity, with a diminution and/or advancement in its 
timing. Notably, these results suggest that blockade of NR2b-containing 
NMDARs effects the timing of this reproductive event. 
 
INTRODUCTION 
Reproductive processes in females of most mammalian species, including 
primates and rodents, involve two major physiological events that are required for 
maintenance of proper reproductive status. These are the pulsatile release of 
GnRH/LH, which occurs over the course of minutes to hours, and the 
preovulatory GnRH/LH surge, which occurs once during the reproductive (28 day 
menstrual or 4-5 day estrous) cycle. The pulsatile release pattern of GnRH is 
necessary for normal release of the gonadotropins, LH and FSH (Blake et al., 
1980). Under a pattern of continuous GnRH, the GnRH receptors located on the 
pituitary gonadotropes become desensitized to GnRH, resulting in a breakdown 
in the release of LH and FSH. The preovulatory GnRH/LH surge, which occurs 
mid-cycle in response to estrogen positive feedback onto the hypothalamus and 
pituitary, is specific to females that undergo spontaneous ovulation, and this 
event precedes and subsequently drives ovulation. Together, GnRH pulsatile 
release and the preovulatory surge are superimposed upon each other to ensure 
the coordination of reproductive physiological processes with behaviors and 
adaptations to the environment that maximize reproductive success.  
As discussed previously, reproductive senescence in rodents is 
characterized by a diminution of the pulsatile release of GnRH/LH, such that 
pulse amplitude decreases and interpulse interval increases (Estes et al., 1980; 
Karpas et al., 1983; Scarbrough and Wise, 1990). The preovulatory LH surge 
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also shows age-related attenuations, particularly a delay in its onset and lower 
peak concentrations of LH in cycling, middle-aged animals as compared to young 
(Wise, 1984). Additionally, young animals show a temporal change in 
hypothalamic GnRH gene expression that is not present in middle-aged females 
on the day of proestrus (Rubin et al., 1997). Moreover, the co-expression of the 
immediate early gene c-fos in GnRH neurons, an indication that gene 
transcription in GnRH neurons is activated, is much lower in middle-aged than 
young rats (Lloyd et al., 1994). Together, these studies indicate that there is a 
loss of drive from the GnRH system as the animal ages. 
Just as the NMDAR contributes to GnRH/LH pulsatility, it also modulates 
the GnRH/LH surge. In young animals, administration of the NMDAR antagonist 
MK-801 to proestrous females not only blocks the LH surge, but also results in a 
less prominent increase in GnRH mRNA expression in the hypothalamus as 
compared to controls (Suzuki et al., 1995). Additionally, NMDAR activation leads 
to increased GnRH gene expression in the hypothalamus (Gore et al., 2000a). 
The ability of NMDA agonists to enhance preovulatory GnRH/LH release is 
diminished with age, as in vitro administration of NMDA results in an attenuated 
response of the GnRH surge in middle-aged caudal hypothalamic explants (Zuo 
et al., 1996). Furthermore, whereas NMDAR agonists stimulate GnRH gene 
expression in young rats on proestrus, these substances actually decrease 
GnRH mRNA levels in middle-aged rats (Gore et al., 2000a). 
In the previous chapter, the role of the NMDAR-NR2b subunit on LH 
pulsatile release was examined by studying effects of the NR2b selective 
antagonist, ifenprodil. That study demonstrated an enhancement of LH pulsatile 
release by ifenprodil. In the present chapter, I determined the contribution of the 
NMDAR-NR2b subunit to the regulation of the GnRH/LH surge, using the same 
NR2b selective antagonist. My hypothesis was that since the co-expression of 
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the NR2b subunit in GnRH neurons increases with age (Miller & Gore, 2002), 
blockade of receptors containing this subunit may facilitate or enhance the 
steroid-induced GnRH/LH surge. 
 
METHODS 
Animals 
A total of 43 middle-aged (10-12 mos.) female Sprague-Dawley rats were 
used in this study. All were purchased from The University of Texas at Austin 
Animal Resource Center rat colony (Austin, TX), which contains animals received 
and bred from Harlan Sprague-Dawley, Inc. (Indianapolis, IN). Animals were 
group housed (2-3/cage) in a temperature-controlled room (21-22°C) with a 12-h 
light, 12-h dark reverse cycle (lights on at 0100h). Food (standard rat chow) and 
water were provided ad libitum. All animal protocols were conducted in 
accordance with the Guide for the Care and Use of Laboratory Animals (National 
Research Council, 1996) following protocols approved by The University of 
Texas at Austin IACUC.  
 
Surgical Procedures 
The cycling status of middle-aged animals was first determined through 
examination of daily vaginal cytology, observed for a minimum of 10 days. Rats 
were characterized as irregularly cycling (6+ day estrous cycles) or acyclic 
(persistent estrus). Cycling animals were ovariectomized (OVX) at 1000-1200 h 
on diestrus (for irregularly cycling animals) or persistent estrus (middle-aged, 
acyclic animals). Surgeries were performed under isoflurane gas anesthesia and 
rats were treated post-operatively with 5 mg/kg Rimadyl. Four weeks later (day 
0), animals were implanted with a jugular catheter (Maffucci et al., 2008) and a 
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1.5 cm long Silastic capsule (capsule dimensions: inner diameter 1.96 mm; outer 
diameter 3.18 mm) containing 5% 17β-estradiol/95% cholesterol (E2), under 
isoflurane anesthesia. This capsule length is known to diffuse E2 in an amount 
that is physiologically relevant for the size of middle-aged female rats (250-300g) 
(Adams et al., 2001b). Following surgery, animals were housed individually. In 
cases where the jugular catheter did not remain patent through serial blood 
sampling, animals were given a new catheter in the left jugular vein and serial 
blood sampling was resumed 1 day following re-catheterization surgery. There 
was no effect of this process on any results. 
 
Serial Blood Sampling 
On days 3 and 4, beginning at 1000h, animals were placed in aquaria 
divided into two chambers with no visual or tactile contact. This length of time of 
E2 replacement is sufficient to stimulate an E2-induced LH surge in cycling 
animals (Wise, 1984). Prior to this, animals were acclimated to aquaria for 20 
minutes on days 1 and 2. Catheters were attached to St. Gobain tubing (inner 
diameter 0.508 mm; outer diameter 1.524 mm; VWR #63018-044), attached to a 
22 gauge needle with a 3cc syringe filled with 5U/mL heparinized saline. 
Syringes were suspended from the top of the aquaria, allowing the animals to 
move freely during serial blood sampling. Beginning at 1100h 0.2 cc of blood was 
collected into heparinized microcentrifuge tubes (1000 U/mL) every hour for 10 
hours. Following each collection, bloods were centrifuged at 600 x g for 5 
minutes. Serum was collected and stored on dry ice. The remaining red blood 
cells were resuspended in an equal volume of 5U/mL of heparinized saline and 
reinfused into the animal in order to maintain hematocrit levels. 
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Drug administration 
Animals were administered either vehicle (0.1% tartaric acid at a volume 
equal to the ifenprodil dose) or ifenprodil tartrate (10 mg/kg BW; ddH2O; Sigma-
Aldrich, St. Louis, MO) intraperitoneal (i.p.) following two hours of serial blood 
sampling. This dose was chosen based on previous in vivo experiments, showing 
it to be effective for i.p. injections in both mice and rats (Narita et al., 2000; 
Rodrigues et al., 2001), and data from our lab (Maffucci et al., 2008). Animals 
received one treatment on day 3, and the opposite treatment on day 4.  
 
Collection of trunk blood 
Following day 4 of serial blood sampling, animals were humanely 
euthanized by decapitation. Trunk bloods were collected, allowed to clot, and 
centrifuged at 6000 x g. Serum was stored at -80°C for later LH and estrogen 
radioimmunoassay.  
 
Radioimmunoassay (RIA) 
LH: LH in serum samples was determined in single samples using double 
antibody RIA. This RIA was performed using the rat LH RP-3 standard, iodinate 
and antibody from the National Hormone and Pituitary Program of the NIDDK 
(kindly provided by Dr. A.F. Parlow). Two assays were performed. The assay 
sensitivity was 0.03 ng/tube at 85% binding. The intraassay variability was 2.98% 
and 3.0%, respectively. Interassay variability was 3.28%. 
 
Estradiol: 17β-estradiol levels were determined in serum samples from trunk 
bloods in a subset of sampled animals due to limited availability of serum. The 
DSL ultrasensitive estradiol DSL kit (DSL-4800, Diagnostic Systems 
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Laboratories, Inc., Webster, TX) was used according to the included instructions. 
Samples were run in duplicate in a single assay. The intraassay variability was 
2.58%. 
 
Statistical analysis 
Any animal with multiple data points reaching minimal or maximal 
detectability of the LH RIA assay was excluded. Remaining animals were 
grouped and analyzed by estrous cycle status (irregularly cycling versus acyclic). 
Post-injection data points were normalized to pre-injection baseline values for 
each animal. A repeated measures analysis of variance was run on each group 
(irregularly cycling and persistent estrus) using SPSS v.11 for Macintosh. The 
Greenhouse-Geissler test statistic was used to measure within subjects effects 
(variables: time and time by drug interactions), as assumed sphericity was 
disproven using Mauchly’s test of sphericity. Between subjects effects (variable: 
drug treatment) were also determined.  Significance was set at p < 0.05. Dr. 
Shanna Hale, a statistician at The University of Texas at Austin Divisions of 
Statistics and Scientific Computation, provided consultation on these 
methodologies.  
 
RESULTS 
Effects of ifenprodil on the 17β-estradiol induced LH surge 
The LH profiles (normalized to pre-injection values) for one representative 
animal from the irregularly cycling and acyclic groups are shown in Figure 4.1 (A 
and B, respectively). The solid line indicates vehicle injected; the dashed, 
ifenprodil injected.  Figure 4.2 shows averaged group data for these treatments. 
Rats in the irregularly cycling group only showed a normal LH surge with vehicle 
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treatment. Ifenprodil injection in this group resulted in a rapid increase, followed 
by a decline, in LH (Figures 4.1A and 4.2A). Acyclic animals showed no LH 
surge, and no effect of treatment versus vehicle (Figures 4.1B and 4.2B).  
In total 43 middle-aged (10-12 mos.) female Sprague-Dawley rats were 
used in this study, 23 irregularly cycling and 21 persistent estrous females Any 
animal with multiple data points reaching minimal or maximal detectability of the 
LH RIA assay was excluded. Thus, final N’s were as follows: Irregularly cycling 
vehicle = 3, irregularly cycling ifenprodil = 4, acyclic vehicle = 4, acyclic ifenprodil 
= 5. A multivariate test statistic could not be calculated for the irregularly cycling 
group due to insufficient residual degrees of freedom. There was neither an 
effect of time (p = 0.327) or an interaction of time by drug (p = 0.71) in the acyclic 
group. Accordingly, tests of within subjects effects (variables: time and time by 
drug interactions) and between subjects effects (variable: drug) were not 
significant (p = 0.144, 0.677, and 0.772, respectively).  
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Fig. 4.1: Representative data of effects of ifenprodil on the estradiol-induced LH 
surge of middle-aged, female rats 
 
Figure 4.1: Individual profiles of LH release, measured in serum samples collected hourly, in 
irregularly cycling and acyclic middle-aged OVX, 17β-estradiol treated animals (A and B 
respectively) given ifenprodil (10 mg/kg; dotted line) or vehicle (0.9% tartaric acid in water; solid 
line). LH values were normalized to pre-injection baseline LH levels. Arrows indicate the time of 
injection (15-minutes following time point 0h). 
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Fig. 4.2: Effects of ifenprodil on the estradiol-induced LH surge of middle-aged, 
female rats 
 
Figure 4.2: LH values for each time point were averaged and plotted to demonstrate group LH 
data normalized to pre-injection, baseline LH levels. Irregularly cycling, OVX, 17β-estradiol 
treated animals (A) given ifenprodil (10mg/kg; dotted line) showed an immediate increase in 
serum LH levels, followed by a decline to baseline levels, as compared to vehicle-treated 
animals (solid line). Vehicle treated animals showed the expected LH surge, beginning at time 
point 2 (1400h). Acyclic, OVX, 17β-estradiol treated animals (B) showed an absence of an LH 
surge in both treatment groups, and hence no effect of ifenprodil on the LH surge. Injection was 
given 15-minutes following time point=0h, as indicated by the arrows.  
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17β-Estradiol levels in middle-aged, ovariectomized female rats 
The average E2 level for a subset (N=3) of the irregularly cycling, middle-
aged rats was 95.09 ± 11.60 pg/ml. The average E2 level for a subset (N=5) of 
the acyclic middle-aged females was 596.94 ± 66.41 pg/ml. Visual observation of 
uterine sizes confirmed that these animals were exposed to estrogen. Their uteri 
were large and fluid filled, indicative of estradiol exposure, whereas counterparts 
treated with vehicle capsules showed small, non-fluid filled uteri (Adams, 1988; 
Stygar et al., 2003).  
 
DISCUSSION 
The present results show that the ability of estradiol to induce a GnRH/LH 
surge is maintained in middle-aged rats that are still exhibiting irregular estrous 
cycles prior to OVX. These animals exhibit a distinct LH surge that begins at time 
point 4 (1400h), consistent with the previous literature (Wise, 1984). By contrast, 
animals of the same age that have entered persistent estrus and are acyclic prior 
to OVX do not experience an LH surge. Our finding indicates that the ability of 
the hypothalamic GnRH neural network to respond to steroid positive feedback 
undergoes a permanent alteration that precedes reproductive failure and that 
cannot be restored by exogenous estradiol. This result is consistent with that of 
Mills et al. (Mills et al., 2002) who showed that the ability of estradiol to up-
regulate the progesterone receptor in the anteroventral periventricular nucleus 
was lost in animals that were farther along in reproductive failure compared to 
rats that were early in reproductive failure. Together these results suggest an 
age-related loss of function of the central neural circuitry controlling the GnRH/LH 
surge. 
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Although our current study must be interpreted cautiously due to low 
statistical power, the data suggest that blockade of NR2b-containing NMDARs by 
ifenprodil accelerates the LH surge in middle-aged rats that were irregularly 
cycling prior to OVX. The profiles of LH release in these rats are consistent with 
an advancement of its timing. Within the first 3 hours of ifenprodil administration, 
LH levels more than doubled as compared to controls, and then dropped to 
baseline and remained at this level beginning between time points 3 and 4 
(1330h).  
Acyclic animals of both vehicle and ifenprodil treatment showed no LH 
surge. This could be interpreted as an effect of the unexpected 
supraphysiological levels of 17β-estradiol circulating in these animals. The large 
(6-fold) increase in estradiol levels from previously irregularly cycling and acyclic 
animals is surprising, as these groups received Silastic capsules prepared in the 
same batch. It is possible that the previously acyclic female takes a longer period 
of time to completely breakdown exogenous estradiol than previously irregularly 
cycling animal. Mori et al. (Mori, 2007) demonstrated that a variety of gene 
transcripts related to the P-450 family of cytochromes, a family that includes 16α-
hydroxylase, the enzyme responsible for the degradation of estradiol, declines in 
the liver with age. It is also likely that animals in the acyclic state exhibit a 
difference in the metabolism of the exogenous hormone, thus accounting for this 
difference. However, regardless of these supraphysiological levels of estradiol, 
acyclic animals did not surge. It is possible that these high levels were still 
exerting negative feedback on the system at days 3 and 4 post treatment. 
However, in females, acyclicity is accompanied by a loss of spontaneous 
ovulation and the preovulatory LH surge (Huang et al., 1978; Lu et al., 1979), 
which cannot be recovered with E2 replacement alone (Matt et al., 1987; Day et 
al., 1988; Tsai et al., 2004). Thus, in the absence of progesterone, an LH surge 
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would not be expected in these animals (Lu et al., 1981; Tsai et al., 2004). 
Administration of ifenprodil did not recover the surge, suggesting NMDAR-NR2b 
subunit does not play a role in maintaining the loss of cyclicity in aging animals.  
The observed effect of ifenprodil on the estradiol-induced LH surge in rats 
that were irregularly cycling prior to OVX is one that warrants further investigation 
in order to determine the precise mechanism at work. Direct application of 
ifenprodil into the rostral hypothalamus at varying time points will allow further 
distinction between a mechanism of inhibition or an advancement of timing. 
Furthermore, addition of a regularly cycling, middle-aged group, and the addition 
of a OVX, E2, progesterone treated group will enhance the information obtained 
concerning effects of the NR2b subunit on the LH surge during the middle-aged 
transition.  
The effect of ifenprodil on the GnRH/LH surge may be exerted not only 
directly on GnRH neurons, but also on other regulatory inputs to the GnRH 
system. An important candidate in this regard is GABA, the inhibitory amino acid 
counterpart to glutamate in the central nervous system. Studies on the role of the 
GABA-A receptor on the preovulatory LH surge suggest that it is involved in the 
timing of this event (Funabashi et al., 1997; Mitsushima et al., 1997). In young 
animals, both GAD67 mRNA expression (the enzyme that synthesizes GABA), 
as well as GnRH gene expression show a distinct rhythmicity surrounding the 
onset of the preovulatory LH surge that is lost in middle-aged females (Rubin et 
al., 1997; Cashion et al., 2004). Therefore, future studies should examine the 
balance between glutamatergic and GABAergic inputs to GnRH neurons, and the 
receptor subunits that mediate these effects, during reproductive aging.  
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Chapter 5: The expression of the NMDA receptor-NR2b 
subunit, and its colocalization with NR1, changes as a 
function of age and estradiol treatment in the AVPV of 
the female rat 
 
ABSTRACT 
Glutamate is an excitatory amino acid that is critical to the regulation of the 
reproductive axis. Changes in the release of this neurotransmitter and its actions 
upon its receptors (NMDA and non-NMDA) contribute to the age-associated 
alterations in reproductive function. Previous studies suggest that the NMDAR 
subunit NR2b undergoes age-associated changes in hypothalamic expression, 
but stereologic analysis has yet to be undertaken. Further, whether the co-
expression of NR2b with the obligatory NR1 subunit undergoes age-related 
changes is similarly unknown. Here, I examined whether the NMDAR-NR2b 
receptor population, both alone and in association with the NR1 subunit, is 
altered as a function of age and/or steroid hormone treatment in the 
anteroventral periventricular (AVPV) nucleus of the hypothalamus, a region that 
is critically involved in the control of reproduction. Young (3-5 mos.), middle-aged 
(9-12 mos.), and aged (~22 mos.) female rats were ovariectomized, 17β-estradiol 
or vehicle (cholesterol) treated, progesterone or vehicle (sesame oil) treated, and 
finally perfused. A 1:2 series of the AVPV was used to label NR2b-
immunoreactive cells using a di-amino benzidine/peroxidase reaction. 
Stereologic analysis showed an age-associated decrease in the density of NR2b-
immunoreactive cells, but no effect of steroid hormone treatment. An additional 
1:4 series of the AVPV was used for immunofluorescent labeling of NR2b as well 
as NR1, to determine the fraction volume of NR1, NR2b, and NR1/NR2b 
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colocalization by confocal analysis. No change in NR1, but an increase of NR2b 
alone was seen as a result of estradiol treatment. This suggests that serum 
estradiol regulates the level of NR2b expression. Further, the fraction volume of 
the NR1/NR2b colocalized subunits showed an age-associated increase, 
suggesting that while fewer cells express the NR2b subunit in the aging AVPV, a 
greater percentage are co-expressed with NR1. Together, these results suggest 
that the subunit composition of NMDARs in the AVPV undergo both age- and 
hormonal-regulation, a finding that may underlie previous observations for 
changes in functional responses to NMDAR agonists with aging.  
 
INTRODUCTION 
Excitatory amino acids are critical to the regulation of the hypothalamic-
pituitary-gonadal (HPG) axis. Their receptors are located throughout the 
hypothalamus, and affect GnRH release directly, via expression on GnRH 
neurons, and/or indirectly, via expression on neurons regulating GnRH release 
(reviewed in (Brann and Mahesh, 1994; Brann, 1995; Mahesh and Brann, 2005)). 
Glutamate is one such neurotransmitter and works via both NMDA and non-
NMDA receptors to modulate this system.  
The focus of this study is the NMDA receptor (NMDAR), a heteromeric 
receptor composed of various combinations of the seven identified subunits 
(NR1, NR2a-d, NR3a-b). Of these, NR1, NR2a, and NR2b are abundantly 
expressed in the hypothalamus and co-expressed on GnRH cell bodies (Meeker 
et al., 1994; Gu et al., 1999; Mahesh et al., 1999; Gore et al., 2000a; Herman et 
al., 2000; Eyigor et al., 2001; Gore et al., 2002; Chakraborty et al., 2003a). The 
NR1 subunit is believed to be obligatory for a functional channel, whereas the 
NR2 subunits contribute to the channel properties of the receptor (Kutsuwada et 
al., 1992; Monyer et al., 1992a; Monyer et al., 1994; Chen et al., 1999). 
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Therefore, in the hypothalamus, the more likely subunit compositions are: 
NR1/NR2a, NR1/NR2b, or NR1/NR2a/NR2b (Sheng et al., 1994) which result in 
varied functional channel properties (Vicini et al., 1998). These receptors play a 
physiological role in the regulation of the reproductive axis, as administration of 
NMDAR agonists excite, and antagonists inhibit, GnRH release in vitro 
(Bourguignon et al., 1989b; Arias et al., 1993; Arias et al., 1996) and LH release 
in vivo (Arslan et al., 1988; Lopez et al., 1990; Brann and Mahesh, 1991a; Farah 
et al., 1991; Ping et al., 1994a, 1995). Furthermore, many of these endpoints 
change with the onset of reproductive aging (reviewed in (Gore, 2001)), although 
the mechanisms behind these changes have yet to be identified. Due to the 
importance of the NMDAR composition in determining channel kinetics, it is likely 
that age-associated changes to the subunit population of these receptors in the 
hypothalamus would influence changes accompanying or possibly even involved 
in causation of the onset of reproductive aging.  
Previous studies examining age-associated changes to the stoichiometry 
of the hypothalamic population of NMDARs have focused primarily on mRNA 
expression of large macro-dissections of the hypothalamus. These studies 
demonstrated that the NMDAR is regulated in a regionally specific manner, a 
steroid hormone specific manner, and that subunit expression levels change with 
age (Zuo et al., 1996; Gore et al., 2000a; Gore et al., 2002). Studies focusing on 
protein expression of these subunits at a more micro-scale (in specific 
hypothalamic nuclei) showed an age-related decline in NR1 levels in the 
anteroventral periventricular nucleus (AVPV) (Chakraborty et al., 2003b), and an 
increase in the co-expression of the NR2b subunit on GnRH neurons in the 
organum vasculosum of the laminae terminalis (OVLT-POA) (Miller and Gore, 
2002). Furthermore, prior and ongoing studies in our laboratory demonstrated 
that the administration of the NR2b selective antagonist ifenprodil results in the 
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upregulation of various parameters of LH pulsatile release in young and middle-
aged rats (Maffucci et al., 2008) and a disruption of the LH surge in middle-aged 
rats (Maffucci & Gore, unpublished) in OVX, estradiol-treated females, and that 
this is estradiol-dependent. These data suggest that the NR2b subunit, 
specifically, plays an important regulatory role in two very important physiological 
aspects of the female reproductive system, GnRH/LH pulsatile release and the 
GnRH/LH surge, and is subject to age-associated changes in expression level. 
However, regional populations of the NR2b subunit alone, and co-expression 
with the obligatory NR1 subunit, have not been examined. Therefore, the current 
study examines age-associated changes in expression of the NR2b subunit in 
the anteroventral-periventricular (AVPV), and effects of steroid hormone 
treatment. This nucleus was chosen for its role as an integration center for 
somatosensory pathways and GnRH neurons (reviewed in (Simerly, 2002)) and 
its regulatory role in the proper functioning of the GnRH/LH surge and estrous 
cyclicity (Wiegand et al., 1980). Additionally, the AVPV shows high co-expression 
of estrogen receptor alpha and NMDARs (specifically NR1), suggesting that it is 
a likely region for the interaction of estradiol and glutamate signaling 
(Chakraborty et al., 2003a).   
Thus, this study examined both age and hormone associated changes in 
NR2b protein expression using stereological quantification, and age and 
hormone associated alterations in receptors co-expressing NR1 with NR2b using 
confocal analysis, in the AVPV of ovariectomized female rats.  
 
 86 
METHODS  
Animals 
A total of 75 female Sprague-Dawley rats were used for this study. These 
were purchased from The University of Texas at Austin Animal Resource Facility 
rat colony (Austin, TX), which contains animals received and bred from Harlan 
Sprague-Dawley, Inc. (Indianapolis, IN). Animals were young (3-5 mos.), middle-
aged (9-12 mos.) or aged (22-24 mos.). Young animals included both virgin and 
previously bred females, middle-aged and aged animals contained retired 
breeders. No effect of breeding status has been shown in any parameters from 
previous studies in our laboratory (Gore et al., 2000b; Gore et al., 2000a; Adams 
et al., 2001a; Adams et al., 2001b; Gore, 2001). Vaginal smears taken daily 
showed all young animals to be regularly cycling; middle-aged animals were 
irregularly cycling or acyclic (persistent estrus); and aged animals were acyclic 
(persistent estrus or persistent diestrus). Animals were housed 2-3 per cage in a 
temperature controlled (21-22°C) room with a light: dark cycle of 12:12 (lights on 
at 0700h). They were given food (Purina Mills Rodent Diet 5LL2) and water ad 
libitum. All cages received 3” long PVC pipes for enrichment. All animal protocols 
were conducted in accordance with the Guide for the Care and Use of Laboratory 
Animals (National Research Council, 1996) following protocols approved by The 
University of Texas at Austin Institutional Animal Care and Use Committee.  
 
Surgeries 
All rats were bilaterally overiectomized (OVX) under isoflurane anesthesia 
between 0900 and 1200h. Cycling (both regularly and irregularly) animals were 
OVX on diestrus 1 or 2. Rats were treated post-operatively with 5 mg/kg Rimadyl. 
Four weeks later, animals were subcutaneously implanted at 1000h with a 
 87 
Silastic capsule (capsule dimensions: inner diameter 1.96mm; outer diameter 
3.18mm) containing either 5% 17β- estradiol/95% cholesterol (E2) or 100% 
cholesterol (Chol; Sigma-Aldrich, St. Louis, MO) as vehicle, under isoflurane 
anesthesia. Capsules were soaked in 0.9% saline at 4°C for at least 24 hours 
prior to implantation. Young, middle-aged and aged animals received an implant 
1.0 cm, 1.5 cm, or 2.0 cm in length, respectively. Different lengths were used to 
account for body weight differences associated with age differences. These 
capsule lengths and steroid hormone concentration have previously been shown 
to restore circulating estradiol levels to those of the proestrus, young rat in all 
three age groups (Adams et al., 2001b; Gore et al., 2002). Following surgery, 
animals were housed individually. Two days later, at 1000h, half of the animals 
received a subcutaneous injection of progesterone dissolved in ethanol and 
diluted in sesame oil (0.59 mg), a dose sufficient to induce the steroid hormone 
induced LH surge (Gore and Roberts, 1995; Gore et al., 2000b). The other half of 
the animals received a vehicle (sesame oil) control injection. Twenty-four hours 
later, rats were deeply anesthetized with 0.4 mL ketamine (100 mg/mL) and 0.4 
mL xylazine (20 mg/mL). Blood was collected via cardiac puncture and animals 
were then perfused at a rate of 50 mL/min. initially with 1% paraformaldehyde 
followed by 4% paraformaldehyde, 0.125% glutaraldehyde in PBS.  After 
perfusion, the animals were examined for any signs of morbidity. Pituitary glands 
and uteri were extracted; pituitaries were weighed and uterine diameter was 
measured. Bloods were allowed to clot, then centrifuged at 8000 rpm at 4°C. 
Serum was separated and stored at -80°C for future hormone assays. Brains 
were removed from the skull, the hypothalamus was blocked coronally, and 
tissues post-fixed in 4% paraformaldehyde, 0.125% glutaraldehyde overnight at 
4°C. They were then sectioned (40 mm) on a Vibratome (VT 1000S, Leica 
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Instruments, Nussloch Germany) and stored in PBS with 0.1% sodium azide at 
4°C.  
 
Radioimmunoassay (RIA): 
When possible, serum from each animal was assayed for concentrations 
of LH, estradiol, and progesterone levels. However, in some cases either not 
enough serum, or no serum, was collected to test for these levels, or data was 
excluded due to a coefficient of variance > 10% or a statistically significant outlier 
as determined by boxplot graphs followed by verification using the Grubb’s test 
for outliers (Iglewiicz and Hoaglin, 1993).  
 
Luteinizing Hormone (LH): Serum LH was determined in duplicate 50 µl samples 
in the laboratory of Dr. Michael Woller, University of Wisconsin-Whitewater, using 
double antibody RIA. This RIA was performed using the rat LH RP-3 standard, 
iodinate and antibody from the National Hormone and Pituitary Program of the 
NIDDK (kindly provided by Dr. A.F. Parlow). The assay sensitivity was 0.03 
ng/tube at 85% binding. The intra-assay variability was 2.36%. Serum from all 
animals was tested, excepting those that did not have enough serum amounts for 
the assay. Samples determined to be outliers (described above) were excluded. 
 
  
Estradiol: Serum estradiol levels were determined using the DSL ultrasensitive 
estradiol DSL kit (DSL-4800, Diagnostic Systems Laboratories, Inc., Webster, 
TX), a double antibody competitive binding RIA, according to the manufacturer’s 
recommended instructions. Samples were run in duplicate in a single assay (200 
µl). The sensitivity of this assay was 2.2 pg/mL and the intra-assay variability was 
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2.58%. Samples with a CV > 10% or determined to be outliers (described 
previously) were excluded. 
 
Progesterone: Serum progesterone was determined in a coated tube RIA 
according to manufacturer’s protocol (DSL-3900, Diagnostic Systems 
Laboratories, Inc., Webster, TX). Samples (25 µm) were run in duplicate in a 
single assay. The sensitivity of this assay was 0.12 ng/mL and the intra-assay 
variability was 1.98%. Samples in which not enough serum was present, or in 
which a CV > 10% was present or that were determined to be outliers (described 
previously), were excluded.  
 
Immunohistochemistry for light microscopy 
Tissue sections were taken at a 1:2 series across the AVPV. All steps 
were completed on a shaker. Sections were washed in buffer (PBS) at room 
temperature (RT). They were then treated to eliminate endogenous peroxidase 
(3:1 methanol: 3% hydrogen peroxide) for 15 minutes at RT, rinsed in buffer, and 
incubated in 10% normal goat serum (S-1000, Vector Labs, Burlingame, CA) and 
0.1% Bovine Serum Albumin (A9085, Sigma, St. Louis, MO) for 1 hour at RT. 
Sections were incubated in rabbit anti-NMDAR-NR2b polyclonal antibody (0.2 
ug/mL; NB 300-106, Novus Biologicals, Littleton, CO) in 2% normal goat serum 
for 3 days (d) at 4°C. The validation of this antibody has been previously 
described by Adams et al. (Adams et al., 2004). Briefly, Western blot analysis 
was performed across a panel of all NMDAR rat cDNAs transfected into HEK293 
cells. This antibody recognized rat NR2b only.  Primary antibody was omitted in 
control sections. The sections were then incubated in 5% normal goat serum and 
biotynylated goat anti-rabbit IgG (1:600; BA-1000; Vector Laboratories, 
Burlingame, CA) for 1 hour. They were then washed and incubated in avidin-
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biotin-peroxidase complex (PK 6200, Vector Laboratories, Burlingame, CA) for 1 
hour, rinsed again, and developed in a di-amino benzidene (DAB)/peroxidase 
reaction (SK-4100, Vector Laboratories, Burlingame, CA). Sections were rinsed 
and mounted on double-subbed slides, dried at RT, dehydrated in a graded 
alcohol series, counterstained with Nissl stain and coverslipped with DPX 
(44581, Fluka, Steinheim, Germany). Due to the large number of tissues, multiple 
immunohistochemistry runs were performed, each containing at least one animal 
from each of the nine treatment groups. 
 
Stereological analysis 
Stereologic analysis was performed as described previously (Chakraborty 
et al., 2003c; Chakraborty et al., 2003b). Slides were recoded prior to analysis so 
that the investigator was blind to treatment groups. For stereological analysis, 
each AVPV region, counterstained with methyl green, was outlined at low 
magnification (4x) on the live computer image using a rat brain atlas (Swanson, 
2003) as a guide. The AVPV was demarcated anterior-posterior using the 
crossing of the anterior commissure, with the anterior portion located at the level 
of the initial elongation and crossing of the anterior commissure, and the 
posterior region located at the completion of this crossing and the appearance of 
the rostral medial preoptic nucleus. A 100x 1.4 numerical aperture was used to 
achieve optimal visualization of labeled cells during analysis. Only animals with a 
complete AVPV series were quantified. Thus, several animals were excluded due 
to tissue damage, resulting in a final experimental sampling of: young vehicle, 
vehicle (YVV), n = 7; young estradiol, vehicle (YEV), n = 7; young estradiol, 
progesterone (YEP), n = 4; middle-aged vehicle, vehicle (MVV), n = 7; middle-
aged estradiol, vehicle (MEV), n = 6; middle-aged estradiol, progesterone (MEP), 
n = 8; aged vehicle, vehicle (AVV), n = 7; aged estradiol, vehicle (AEV) n = 5; 
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aged, estradiol, progesterone (AEP), n = 5. The software package 
StereoInvestigator (Microbrightfield, Colchester, VT) was used to count labeled 
cells. The program placed dissector frames using a systematic, randomized 
sampling within each contour using a 45 x 45 mm2 grid. DAB-labeled NR2b cells 
were counted within the 45 x 45 mm optical dissector frames on the x-/y- axis. 
The final post-processing thickness of the tissue was determined using the 
SteroInvestigator program, and the average was determined to be 17 mm. The 
counting frame height was kept at 14 mm to stay within those limits and to allow 
a guard zone on the edge of the tissue where tissue may be uneven. Cells were 
counted using the optical fractionator, and as such neuronal number estimates 
are not dependent upon the direct volume of reference of the region, thus any 
shrinkage of tissue should not affect the quantification of labeled cells. 
Furthermore, volume of the AVPV was determined via the outlining of the region 
at 4x, and multiplying this area by the total thickness and the inter-slice distance. 
Density of cells was divided by dividing the extrapolated number of cells, as 
determined by the stereological analysis, by the volume of the AVPV. The 
coefficients of error and variation of the estimates were calculated as described 
previously (Schmitz, 1998; Schmitz and Hof, 2000). Gundersen’s CE for the nine 
groups were: YVV = 0.089, YEV = 0.112, YEP = 0.090, MVV = 0.084, MEV = 
0.110, MEP = 0.111, OVV = 0.096, MEV = 0.096, MEP = 0.124.  
Quantitative analyses were performed using a computer-assisted 
morphometry system including an Olympus photomicroscope (Center Valley, PA) 
equipped with a Ludl Precision2 MAC-5000XYZ computer-controlled motorized 
stage (Hawthorne, NY), and Optronics DC 100U digital camera (Goleta, CA), a 
Dell computer (Austin, TX), and StereoInvestigator morphometry and stereology 
software (Microbrightfield, Inc., Colchester, VT). Stereological methods using the 
optical fractionator in Microbrightfield (West et al., 1991) were used to estimate 
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the cell population of NR2b-immunoreactive cells in the AVPV. Labeled cells 
within the dissector frames were counted on a live computer image at high power 
(100x). The DAB staining of NR2b was easily distinguished from the methyl 
green counterstain. Cytoplasmic membranes labeled for NR2b showed a brown 
cytoplasmic staining, whereas labeling of the nucleus was absent. The methyl 
green counterstain often labeled the nucleus in these cells. Examples are 
provided in Figure 5.1. An appropriate contrast/brightness setting was 
determined, resulting in high-resolution images. These were then transferred to 
Adobe Photoshop and given minor adjustments of contrast and brightness. 
These in no way altered the appearance of the original materials.  
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Fig. 5.1: Micrographs showing the AVPV and NR2b immunoreactive cells in this 
region 
 
Figure 5.1: Representative micrographs of NR2b immunoreactivity at low (4x; A), medium (10x; 
B) and high (100x; C) magnification. Panel A illustrates the AVPV region examined in this study at 
the power in which the contour was drawn for stereology. Panel B shows the entirety of this 
region at a higher magnification. Panel C demonstrates individual NR2b immunoreactive cells 
(brown DAB label), counterstained with Nissl (blue).  
 
Immunofluorescence for confocal microscopy 
 Tissue sections were taken at a 1:4 series across the AVPV. All steps 
were completed on a shaker. Sections were washed in buffer (PBS) at room 
temperature (RT). They were then incubated in 10% normal goat serum (S-1000, 
Vector Laboratories, Burlingame, CA) and 0.1% bovine serum albumin (A9085, 
Sigma, St. Louis, MO) for 1 hour at room temperature. Sections were then 
incubated in rabbit anti-NMDAR-NR2b polyclonal antibody (0.2 mg/mL; NB 300-
106, Novus Biologicals, Littleton, CO) and mouse anti-NR1 antibody (5 mg/mL; 
54.1 kindly provided by Dr. John H. Morrison) in 2% normal goat serum for 3 d at 
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4°C. Both of these antibodies have been validated as specific (Siegel et al., 
1994; Adams et al., 2004). Sections were then washed in buffer and incubated in 
5% normal goat serum, anti-mouse Alexa-Flour 633 IgG (5 mg/mL; A-210-486, 
Invitrogen, Carlsbad, CA) and anti-goat FITC IgG (3.33 mg/mL; F-2765, 
Invitrogen, Carlsbad, CA) for 1.5 hours at RT. Sections were washed, mounted 
on Superfrost Plus Premium microscope slides (12-550-15 Fisherbrand, 
Pittsburgh, PA), dried, and coverslipped with Vectashield mounting media (H-
1000, Vector Laboratories, Burlingame, CA), and the coverslip perimeter sealed 
with clear nail polish. Sections were kept in low light to protect against 
photobleaching, and stored in the dark at 4°C. Multiple controls were run: 1. 
primary antibody omitted, 2. secondary antibody omitted, 3. both primary and 
secondary antibodies omitted, 4. NR2b primary antibody only, 5. NR1 primary 
antibody only. No specific staining was detected in any of the controls.  
 
Confocal Microscopic Analysis 
An SP2 AOBS Laser Scanning Confocal Microscope (Leica Microsystems 
Inc, Exton, PA) was used to determine NR1 and NR2b expression and co-
labeling in the AVPV. Subsections of the AVPV measuring 375 mm x 375 mm x 
15 mm were imaged with a 40X (1.25NA) oil objective at 1.00 zoom. Image 
stacks were acquired sequentially at excitation wavelengths of 488 nm and 633 
nm and emission was collected between 500 nm and 510 nm for FITC -labeled 
NR2b and 640 nm and 680 nm for Alexa Fluor 633-labeled NR1 with a 1.0 um z-
axis step size. The 15 mm depth was chosen to ensure equal penetration of both 
antibodies across the entire scan. Scans were conducted over 7 sequential days 
in order to minimize photobleaching of antibodies, and to avoid “drift” in the 
confocal, with laser parameters remaining constant. Initial scans were done in 
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duplicate, using both a high and low laser setting to protect against saturating 
levels of immunofluorescence. At the end of day 1, it was determined that no 
saturation was present at the high laser setting and subsequent tissues were 
then scanned on this high setting only. At the start of each day, the last sample 
from the previous day was rescanned to control for possible shifts in the laser 
readings. These were later compared using a paired t-test to determine any 
significant differences, of which there were none. In total, 5 regions were 
scanned over the three tissue sections, with one region encompassing the entire 
rostral AVPV slice, and 2 regions (one ventral and one dorsal) per each caudal 
AVPV slice (Figure 5.2). Examples of immunofluorescence and co-expression 
are shown in Figure 5.3. 
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Fig. 5.2: Illustration of the sampling technique used to study NMDAR 
immunoflourescence in the AVPV 
 
 
Figure 5.2: Depiction of the sampling methodology used for the confocal analysis of NR1 and 
NR2b immunofluorescence in the AVPV from rostral (top) to caudal (bottom). The dashed line 
represents the AVPV region. Inner dotted circles represent the approximate area scanned for 
each tissue section. 
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Fig. 5.3: Representative micrographs demonstrating immunoflourescent staining 
of the NMDAR subunits 
 
Figure 5.3: Representative confocal micrographs, taken at 40x magnification with 1.84 zoom. 
Micrographs demonstrate immunofluorescent labeling of cells in the AVPV: NR1 (A, D, G), NR2b 
(B, E, H), and an overlay of NR1 and NR2b (C, F, I). Panel C shows NR1+/NR2b- (red only) and 
panel F shows NR1-/NR2b+ (green only) labelling. NR1+/NR2b+ immunofluorescent cells are 
shown in panel I.  
 
Imaris 5.7.0 software (Bitplane Scientific Solutions, Zurich, Switzerland) 
was used to individually analyze scans in three dimensions. All scans were 
coded to keep treatment and age of each animal unknown.  Sub-regions of 293 
mm x 293 mm were analyzed so as to exclude the third ventricle and the 
threshold levels determined to subtract background auto-fluorescence. Co-
localization was determined using the IMARIS co-localization algorithms. 
Volumes for NR1, NR2b and co-localization were determined using the iso-
surface function and normalized to the volume of tissue analyzed (858490 mm3).  
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The secondary antibody only control was used to determine any 
nonspecific immunostaining. Alexa 633 showed no non-specific labeling. FITC 
showed negligible labeling. This was determined by analyzing the secondary only 
control (one section from a young, middle-aged, and aged animal) using Imaris, 
with the same parameters as used for experimental tissues. The average of the 
immunofluorescent volumes for these control tissues was taken and subtracted 
from the total volume of immunofluorescence of each experimental tissue. These 
totals were then compared to the unmodified FITC immunofluorescence data and 
no significant difference was determined. Therefore, the background 
immunolabeling had negligible effects on results. 
 
Statistical Analysis  
Steroid Hormones: Outliers were determined and excluded using boxplot graphs 
for initial determination, followed by verification using the Grubb’s outlier test 
(Iglewiicz and Hoaglin, 1993). Two-way ANOVA was used to determine age-
related differences in serum hormone levels and to verify differences in hormone 
treatments using SPSS 11 for Macintosh (variables: age and steroid hormone 
treatment). When indicated, post hoc analysis using Fischer’s protected least 
significant difference test was used. Significance was set at p < 0.05.  
 
Stereology: Variables were plotted on a box plot and possible outliers 
determined. These were verified using the Grubb’s outlier test (Iglewiicz and 
Hoaglin, 1993) and excluded when confirmed. Two-way ANOVA was used to 
determine age and steroid hormone associated differences in the number and 
density of NR2b immunoreactive cells, as well as the volume of the AVPV. These 
were determined using SPSS 11 for Macintosh (variables: age and steroid 
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hormone treatment). When indicated, post hoc analysis was performed using 
Fischer’s protected least significant difference test. Significance was set at p < 
0.05. No differences were observed in middle-aged females irregularly cycling 
prior to OVX (N=6) when compared to those in persistent estrus (N=15), so these 
groups were combined.  
 
Confocal microscopy: Variables were plotted on a box plot and possible outliers 
determined. These were verified using the Grubb’s outlier test (Iglewiicz and 
Hoaglin, 1993) and excluded when confirmed. Two-way ANOVA was used to 
determine age and steroid hormone associated differences in the volume of NR1 
and NR2b immunofluorescence, as well as the volume of NR1/NR2b colocalized 
immunofluorescence. These were determined using SPSS 11 for Macintosh 
(variables: age and steroid hormone treatment). When indicated, post hoc 
analysis using Fischer’s protected least significant difference test was used. 
Significance was set at p < 0.05. No differences were observed in middle-aged 
females irregularly cycling prior to OVX (N=6) when compared to those in 
persistent estrus (N=15), so these groups were combined.  
 
RESULTS 
Serum hormone levels of LH, E2, and P4 as a function of age or hormone 
treatment 
Data presented in this section represent animals whose tissues were used 
for this study, in combination with those that were excluded due to tissue damage 
or sample size requirements. All animals were treated with the same protocol 
and within the same cohort, and thus the data is representative of those animals 
used for stereologic and confocal analysis.  
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Luteinizing Hormone: 
 LH levels varied significantly as a function of both age (p < 0.001) and 
hormone (p < 0.001) treatment (Table 5.1) among all treatment groups, as 
expected. Young animals had higher levels than both middle-aged and aged (p = 
0.001 and p < 0.001) and middle-aged animals were higher than aged (p < 
0.001). 
Table 5.1: Serum hormone levels of young, middle-aged, and aged 
ovariectomized female rats. 
Age Hormone  
Treatment 
LH (ng/mL) Estradiol  
(pg/mL) 
Progesteron
e (ng/mL) 
Vehicle 17.71 ± 1.92 
(N=8)  
27.98  ± 15.75 
(N=6) 
8.97 ± 2.83 
 (N=8)  
Estrogen 8.37 ± 0.37  
(N=6) 
187.74 ± 42.12 
(N=8) 
10.51 ± 2.73  
(N=8) 
Young 
Estrogen/ 
Progesterone 
8.00 ± 0.88  
(N=6) 
135.87 ± 10.47 
(N=6) 
15.48 ± 2.34  
(N=7) 
Vehicle 8.34 ± 0.35 
(N=7) 
94.24 ± 24.09 
(N=8) 
7.47 ± 1.02 
(N=7) 
Estrogen 10.68 ± 1.58 
(N=8) 
141.61 ± 43.12 
(N=8) 
10.75 ± 2.17 
(N=8) 
Middle-
aged 
Estrogen/ 
Progesterone 
6.03 ± 0.24 
(N=7) 
200.72 ± 30.63 
(N=8) 
15.51 ± 2.17 
(N=8) 
Vehicle 3.27 ± 0.56 
(N=6) 
345.89 ± 86.38 
(N=10) 
7.24 ± 1.36 
(N=10) 
Estrogen 4.60 ± 2.20 
(N=2) 
214.51 ± 15.13 
(N=5) 
11.23 ± 2.46 
(N=6) 
Aged 
Estrogen/ 
Progesterone 
3.28 ± 0.62 
(N=8) 
165.03 ± 19.36 
(N=8) 
15.52 ± 7.33 
(N=8) 
Table 5.1: LH values showed a main effect of age (p < 0.001) and hormone treatment (p < 
0.001). Estradiol levels showed a difference with age (p=0.004), but not steroid hormone 
treatment (p=0.834), and an interaction of the two variables (p = 0.004). Unexpectedly, levels 
were high in all groups, likely due to contamination of the samples. Thus, these data are likely 
not representative of actual estradiol levels. Progesterone levels did not vary with age 
(p=0.843), but were significantly different between steroid hormone treatments (p < 0.001). 
Mean ± S.E.M. are shown. 
 
Estradiol:  
Although the estradiol RIA worked well as indicated by the standard curve 
and controls, serum estradiol concentrations in the experimental animals were 
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unexpectedly high, even in four-week OVX rats. I believe that because the blood 
samples were collected in the hood via cardiac puncture just prior to perfusion, 
and the same hood was used to prepare the estradiol capsules, there may have 
been some free estradiol in the hood that contaminated the samples. Thus, while 
I present estradiol results in Table 5.1, I do not believe they accurately reflect the 
circulating estradiol concentrations in our rats, as these far exceed those of 
published studies (Gore et al., 2002). Notably, as discussed below, the uterus 
and pituitary responses to estradiol were consistent with the absence (OVX + 
vehicle + vehicle)) or presence (OVX + E2 +/- P4) of estradiol 
. 
Progesterone:  
As shown in Table 5.1, progesterone levels did not vary with age 
(p=0.840), but were significantly different between hormone treatments (p < 
0.001), with progesterone treated groups showing significantly higher levels than 
estradiol only (p=0.014) and vehicle only (p < 0.001) treated animals.  
 
Pituitary weights and uterine diameter as a function of age or hormone 
treatment 
Note that data presented in this section represent a combination of 
animals whose tissues were used for this study, and those that were excluded 
due to tissue damage or sample size requirements. All animals were treated with 
the same protocol and within the same cohort, and thus the data is 
representative of those animals used for stereologic and confocal analysis.  
 
Pituitary weights:  
Pituitaries were removed and examined, and animals with observable 
tumors were excluded. Pituitary weights of healthy animals showed no 
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differences with age (p=0.246), and had an effect approaching significance 
(p=0.051; Table 5.2). Animals treated with estradiol only had a significantly 
higher pituitary weight (p=0.027), and the increased weights of estradiol 
treatment followed by progesterone approached significance (p=0.064) 
compared to those treated with vehicle. The increased pituitary weight of both 
groups treated with estradiol suggests estradiol-induced cell hypertrophy 
(Adams, 1988; Hana et al., 1998; Abech et al., 2005), and supports that vehicle 
treated animals did indeed have much lower levels of estradiol than estradiol 
treated animals.  
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Table 5.2: Pituitary weight and uterine diameter of young, middle-aged, and aged 
ovariectomized female rats 
 
Age Hormone 
Treatment 
Pituitary Weight 
(normalized to body 
weight) 
Uterine Diameter 
(mm) 
 
Vehicle 
 
4.75 x 10-5 ± 1.88 x 10-6 
(N=4) 
 
1.36 ± 0.10 
(N=8) 
 
 
Estrogen 
 
6.18 x 10-5 ± 2.59 x 10-6 
(N=7) 
 
4.83 ± 0.37 
(N=7) 
 
 
Young 
 
Estrogen/ 
Progesterone 
 
6.07 x 10-5 ± 3.87 x 10-6 
(N=7) 
 
8.34 ± 0.73 
(N=7) 
 
 
Vehicle 
 
4.96 x 10-5 ± 2.70 x 10-6 
(N=7) 
 
2.13 ± 0.22 
(N=8) 
 
 
Estrogen 
 
5.58x 10-5 ± 3.54 x 10-6 
(N=4) 
 
3.86 ± 0.99 
(N=8) 
 
 
Middle-
aged 
 
Estrogen/ 
Progesterone 
 
6.80x 10-5 ± 3.67 x 10-6 
(N=4) 
 
4.91 ± 0.41 
 (N=8) 
 
Vehicle 
 
5.81 x 10-5 ± 1.26 x 10-6 
(N=5) 
 
 
2.39 ± 0.38 
(N=7) 
 
Estrogen 
 
7.93 x 10-5 ± 2.28 x 10-6 
(N=4) 
 
 
4.60 ± 0.25 
(N=2) 
 
Aged 
 
Estrogen/ 
Progesterone 
 
6.09 x 10-5 ± 1.08 x 10-6 
(N=4) 
 
 
4.10 ± 0.39 
(N=8) 
Table 5.2: Pituitary weights did not vary significantly with age, but had a main effect of hormone 
treatment (p=0.051). Uterine diameter measurements showed no age associated differences, 
but had a main effect with hormone treatment (p < 0.001). Mean ± S.E.M. are shown. 
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Uterine Diameter:  
Uterine diameter measurements had no age associated differences 
(p=0.890), but had a main effect with hormone treatment (p < 0.001; Table 5.2). 
Uterine weights were not taken, as the ovariectomy procedure includes removing 
a portion of the uterus. Thus uterine diameter is a more accurate representation 
of the uterotropic response to estradiol treatment. Animals treated with 
estradiol/vehicle or estradiol/progesterone had significantly higher uterine 
diameters than those receiving vehicle (p < 0.001), and did not differ from one 
another (p=0.890). In addition, It was noted that all animals receiving estradiol 
treatment had an enlarged, fluid-filled uterus as compared to animals receiving 
vehicle alone, as described previously (Adams, 1988; Stygar et al., 2003). 
 
Stereologic analyses of changes in NR2b-immunoreactive cell number as a 
function of age or hormone treatment  
Stereologic analyses showed that the number of NR2b immunoreactive 
cells in the AVPV did not change with age (p=0.188) or hormone treatment 
(p=0.261; Figure 5.4), nor was there any interaction among those variables 
(p=0.248). In addition, the AVPV volume did not change with age, hormone, 
ofrtheir interactions (p=0.501, p=0.803 and p=0.736), respectively; Figure 5.5). 
However, the density of NR2b immunoreactive cells within the AVPV decreased 
significantly as a function of age (p=0.017; Figure 5.6A), but not hormone 
treatment (p=0.162; Figure 5.6B). Young animals had a significantly higher 
density than aged (p=0.016) and there was a trend for a decrease in density from 
middle-aged to aged animals (p=0.083; Figure 5.6A). There was a trend for 
interaction among the variables, but no significance (p=0.059; Figure 5.6C). 
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Fig. 5.4: NR2b-immunoreactive cell number in the AVPV does not change as a 
function of age or hormone treatment 
 
Figure 5.4: The number of immunolabeled cells expressing the NR2b subunit in the AVPV does 
not change with age (A) or hormone (B) treatment, nor is there any interaction (C). VV = vehicle, 
vehicle treated; EV = 17β-estradiol, vehicle treated; EP = 17β-estradiol, progesterone treated. 
The numbers at the bottom of each bar represent the number of rats per group.  
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Fig. 5.5: The volume of the AVPV does not change as a function of age or 
hormone treatment 
 
 
Figure 5.5: The volume of the AVPV does not change with age (A) or hormone treatment (B), nor 
is there an interaction among these endpoints (C). VV = vehicle, vehicle treated; EV = 17β-
estradiol, vehicle treated; EP = 17β-estradiol, progesterone treated. The numbers at the bottom of 
each bar represent the number of rats per group.  
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Fig. 5.6: NR2b-immunorective cell density decline as a function of age, but does 
not change with hormone treatment 
 
Figure 5.6: The density of NR2b immunoreactive cells decreases as a function of age in the 
AVPV (A; p=0.024), but does not change with steroid hormone treatment (B), nor is there an 
interaction of these variables (C). VV = vehicle, vehicle treated; EV = 17β-estradiol, vehicle 
treated; EP = 17β-estradiol, progesterone treated; * p < 0.05. The numbers at the bottom of each 
bar represent the number of rats per group.  
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Confocal analysis of changes in NR2b and NR1-immunofluorescence as a 
function of age or hormone treatment 
There was no main effect of age (p=0.291) or hormone treatment 
(p=0.740) for the fraction volume of NR1 immunofluorescence, nor were there 
any interactions (p=0.863; Figure 5.7). There was also no main effect of age 
(p=0.832; Figure 5.8A) for the fraction volume of NR2b immunofluorescence. 
However, hormone treatment did cause an effect (Figure 5.8B). Animals treated 
with estradiol only showed an increase in the fraction volume of NR2b-if as 
compared to vehicle treated animals (p=0.034; Figure 5.8B). This effect was no 
longer seen in the estradiol plus progesterone group (Figure 5.8B). There was 
no interaction of these age and hormone treatment (p=0.480; Figure 5.8C).  
In examining the fraction volume of colocalization these two subunits, 
there were main effects of age (p=0.029; Figure 5.9A), but not hormone 
treatment (p=0.107; Figure 5.9B), and no interaction of these variables (p=0.864; 
Figure 5.9C). Specifically, colocalization fraction volumes increased throughout 
the aging process, with both young and middle-aged animals having lower levels 
than aged (p=0.008 and p=0.050 respectively; Figure 5.9B). Additionally, while 
not quantified, it was noted that a high percentage of the NR2b population was 
expressed with NR1, with a much smaller population being expressed in the 
absence of NR1.   
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Fig. 5.7: The fraction volume of NR1-immunofluorescent cells does not change in 
the AVPV as a function of age or hormone treatment 
 
Figure 5.7: The fraction volume of immunofluorescent NR1 in the AVPV does not change as a 
function of age (A) or steroid hormone treatment (B), nor is there an interaction of these variables 
(C). VV = vehicle, vehicle treated; EV = 17β-estradiol, vehicle treated; EP = 17β-estradiol, 
progesterone treated. The numbers at the bottom of each bar represent the number of rats per 
group.  
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Fig. 5.8: The fraction volume of NR2b-immunofluorescent cells does not change 
in the AVPV as a function of age, but increases with estradiol 
treatment 
 
Figure 5.8: The fraction volume of immunofluorescent NR2b in the AVPV does not change as a 
function of age (A), but does increase with estradiol treatment (B). There is no interaction of these 
variables (C). VV = vehicle, vehicle treated; EV = 17β-estradiol, vehicle treated; EP = 17β-
estradiol, progesterone treated; * p < 0.05. The numbers at the bottom of each bar represent the 
number of rats per group.  
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Fig. 5.9: The fraction volume of NR1 & NR2b-immunofluorescent cells 
(coexpressed) in the AVPV increases with age and does not change 
as a function hormone treatment 
 
Figure 5.9: The fraction volume of NR1 and NR2b colocalized in the AVPV increases with age 
(A) and estradiol treatment (B), but these two variables do not interact (C). VV = vehicle, vehicle 
treated; EV = 17β-estradiol, vehicle treated; EP = 17β-estradiol, progesterone treatedl; * p < 0.05, 
** p < 0.01. The numbers at the bottom of each bar represent the number of rats per group.  
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DISCUSSION 
The present study was undertaken to determine if age-associated 
changes in the NMDAR are present in the anteroventral periventricular nucleus 
(AVPV) of the hypothalamus. This is a sexually dimorphic nucleus in the 
hypothalamus important to the proper maintenance of female reproductive 
physiology via integration of GnRH, steroid hormone, and neuromodulatory 
signals, resulting in normal reproductive cycles and ovulation (Wiegand et al., 
1980; Simerly, 2002; Chakraborty et al., 2003a). This study specifically examined 
the age- and hormone-specific changes to the expression of the NR2b subunit, 
and the colocalization of the NR1/NR2b functional channel, the former based on 
evidence that the NR2b subunit is particularly likely to undergo changes with 
aging, both on GnRH neurons and in surrounding hypothalamic regions (Gore et 
al., 2000a; Gore et al., 2002; Miller and Gore, 2002) and the latter because the 
NR2b is not thought to represent a functional channel unless it is co-expressed 
with the NR1 subunit (Saito et al., 2003). 
Our results suggest that NMDAR subunits are undergoing age-associated 
alterations, with some modulation by estradiol. Stereological analysis of NR2b 
cell number and density was not affected by hormone treatment, but the density 
of immunoreactive cells did decrease from young to aged animals. The volume of 
the AVPV showed no change as a function of age or steroid hormone treatment. 
Confocal analysis of the immuofluorescent fraction volume of NR1 alone, NR2b 
alone, and NR1 co-expressed with NR2b showed no steroid hormone 
modification to the NR1 subunit, but an increase NR2b in the presence of 
estradiol only. Addition of progesterone returned this measure to control values. 
Further, an age-associated increase in NR1/NR2b colocalization was observed, 
with young and middle-aged both having a lower immunofluorescent fraction 
volume than aged animals. However, NR1 and NR2b alone showed no age-
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associated change. These results suggest that, while overall the amount of NR2b 
density (by stereology) decreases with age, the volume fraction of the AVPV 
containing co-expressed NR2b with NR1 increases with age. Together, these 
data support a change in stoichiometry of the NMDAR with aging. 
 
Age-related changes in AVPV are limited to specific cell phenotypes 
Although total cell number in the AVPV was not determined as the current 
study focused only on cells expressing NMDARs, the finding that AVPV volume 
did not change as a function of age or hormone treatment, nor were there any 
qualitatively apparent changes in cell size in either brightfield (DAB) or confocal 
(immunofluorescence) studies, suggests that the number of cells that comprise 
the AVPV remains static. This is further supported by other studies examining the 
ventromedial nucleus, arcuate nucleus, and medial preoptic area of the 
hypothalamus, in which no age-related change in neuronal cell number has been 
found (Leal et al., 1998; Madeira et al., 2000; Madeira et al., 2001). Such a lack 
of overall cell loss in the hypothalamus with aging is consistent with the 
suggestion that normal aging is not accompanied by a generalized loss of 
neurons, but rather, a change in the phenotype of existing neurons that may 
have a functional outcome (Finch, 2003). Thus our observed alterations in 
NMDAR subunit expression are likely due to changes in the receptors itself, 
rather than changes to cell number in the AVPV. 
 
The presence of a functional NMDAR in the AVPV  
To date the literature supports that a functional NMDAR must contain both 
the NR1 and NR2 subunits in order to be fully functional (Kutsuwada et al., 1992; 
Monyer et al., 1992a, b). Furthermore, Luo et al. (1997) demonstrated that there 
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are no NR2a/NR2b containing complexes that do not also contain NR1 in the 
adult rat cortex. While no data has been presented to support this same 
phenomenon in the hypothalamus, our current observation that the vast majority 
of NR2b-containing cells are co-expressed with NR1 suggests that in this region, 
most NR2b-containing cells are functional NMDARs. Thus, age-associated 
changes to the NMDAR in the AVPV have physiological consequences, as the 
proportion of neurons containing the NR2b subunit changes with age, and 
consequently, the ability of these NMDARs to bind to glutamate and to generate 
an intracellular signal are likely to differ in the aging AVPV. 
 
Age-associated changes of the NMDAR  
The finding that the density of cells labeled with NR2b decreases with age, 
but the fraction volume of NR2b alone does not change shows that, while the 
volume of NR2b protein within the AVPV is not declining, the number of cells 
expressing this subunit per unit volume is. Together with the additional finding 
that neither the NR1- nor NR2b-immunofluorescent fraction volume changes as a 
factor of age, but their co-expression increases, I interpret these data to indicate 
an increase in the amount of NR2b protein expressed per cell with a decrease in 
the total number of cells expressing this subunit. Thus, as the animal ages, the 
stoichiometry of the functional NMDAR is changing.  
In the adult rat cortex, Luo et al. (Luo et al., 1997)  found that the most 
abundant stoichiometry of the NMDAR contained at least three different subunits, 
NR1, NR2a, and NR2b. Although this has not been shown in the hypothalamus, 
should this be the case, our findings suggest a possible switch from this 
preferred receptor stoichiometry in the young adult, to one in which NR1/NR2b is 
more prevalent. To determine this more conclusively, an analysis of NR1/NR2a 
co-expression is needed, as well as an analysis of these populations on GnRH 
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neurons in the rat AVPV. Although the tissues from this cohort of aging rats were 
exhausted for the current analysis, the Gore lab intends to pursue this avenue of 
research in future studies. 
The implications of our finding that the NR1/NR2b configuration becomes 
more prevalent in the AVPV, although NR2b-immunoreactive cell density 
decreases, are that the channel properties of this receptor, and its translation 
onto its target cells, undergoes age-related alterations. The NMDAR mediates 
calcium signaling, which in turn determines the probability that the channel will 
open. The NR1/NR2a stoichiometry has a much higher channel open probability 
than an NR1/NR2b containing channel (Chen et al., 1999; Erreger et al., 2005). 
These channels undergo multiple conformational changes prior to opening, and 
at least one of these is faster in the NR2a containing channel than the NR2b. 
Thus the signaling profiles for these channels are very different (Erreger et al., 
2005). Further, rapid application of glutamate results in a slower deactivation 
time and slower recovery from desensitization of NR1/NR2b containing receptors 
as compared to NR1/NR2a (Vicini et al., 1998). Finally, excitatory post-synaptic 
currents have a slower decay time when mediated by NR2b containing NMDARs 
as compared to NR2a containing receptors (Flint et al., 1997). An 
NR1/NR2a/NR2b containing cell has a deactivation time course intermediate 
between that of the NR1/NR2a and NR1/NR2b (unfortunately other properties 
have not been tested) (Vicini et al., 1998). These all have important implications 
for the action of these receptors on the cell body. These results suggest that the 
expression pattern of NR2b containing cells in the AVPV, a nucleus important in 
the regulation of female reproductive function, is changing with age, and thus 
supports that these changing receptors have a functional effect on the 
dysregulation of the reproductive axis seen with increased age. Reports that the 
responsiveness of GnRH neurons to NMDAR agonists/antagonists is altered with 
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age (Bonavera et al., 1998; Gore et al., 2000a; Brann and Mahesh, 2005) are 
consistent with age-related changes in functional properties of NMDARs. 
 
Estradiol interacts with the NMDAR 
The ability of glutamate to activate the NMDAR is sensitive to estradiol. 
Studies focusing in the hippocampus have found that estradiol application: 1. 
increased neuronal responsiveness (Weiland, 1992), 2. increased dendritic spine 
density (Gould et al., 1990), 3. increased synapse density (Woolley and McEwen, 
1992), and 4. these structural changes are regulated via an NMDA dependent 
mechanism (Woolley and McEwen, 1994; Woolley et al., 1997). In focusing 
specifically on the hypothalamus, the presence of estradiol has been shown to 
increase NR2b mRNA expression in the preoptic area-anterior hypothalamus 
while NR1 remained static (Brann et al., 1993b; Gore et al., 2002; Ottem et al., 
2002). It also appears to affect the association of NR2b with neuronal nitric oxide 
synthase, a regulatory protein for nitric oxide, a neuromodulator of the 
reproductive axis (Dhandapani and Brann, 2000; Mahesh and Brann, 2005; 
d'Anglemont de Tassigny et al., 2007). Furthermore, NR1 mRNA expression in 
the AVPV specifically increased with steroid hormone treatment (Gu et al., 1999), 
but an alternate study found that this did not translate to the level of the protein, 
as this remained unchanged (Chakraborty et al., 2003b). Notably, receptor 
binding studies showed that estradiol does not affect glutamate binding to the 
NMDAR in hypothalamus and cortex, suggesting a different mechanism of action 
other than receptor binding (Brann et al., 1993a). In addition, a large percentage 
of NR1-containing cells in the AVPV also co-express ERa, suggesting that the 
same cells may mediate actions of both glutamate and estradiol (Chakraborty et 
al., 2003a).  
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The finding that estradiol increased the NR2b -immunofluorescent fraction 
volume in the AVPV, but did not affect NR1 or NR1/NR2b coexpression, supports 
potential interactions between estrogens and NMDAR signaling that appear to be 
subunit specific. Taken together with the stereology data, in which there was no 
effect of estradiol on the number or density of NR2b-immunoreactive cells, the 
increase in the fraction volume of the NR2b-immunofluorescence suggests that 
estradiol enhances protein translation, ultimately resulting in an increased 
amount of protein expressed in each cell, but not an increase in the number of 
cells expressing this subunit. Functionally, this likely translates to an alteration in 
NMDAR function in the reproductive system, and may be a mechanism by which 
the observed enhancement of NMDA agonist application on LH release in young 
hypothalamic explants (Arias et al., 1993) is achieved.  
Notably, this effect of estradiol was not observed when rats were treated 
with progesterone, suggesting some reversal or mitigation of one hormone’s 
effects by the other. I believe the timing of hormone treatment relative to 
euthanasia may underlie some of this effect of progesterone. Ovariectomized 
rats were treated with estradiol, followed 48 hours later by progesterone or 
vehicle. This progesterone treatment rapidly alters neuroendocrine signaling 
such as the GnRH/LH surge, in a manner that initially facilitates but then more 
rapidly terminates estradiol’s actions. Because our rats were euthanized 24 
hours after progesterone it is possible that any facilitation of estradiol’s effects by 
progesterone may have already happened and been terminated. The Gore lab 
hopes to perform future studies at an earlier time point, within 6 hours of 
progesterone treatment, to ascertain whether any such action on the NMDAR 
system may be noted. 
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CONCLUSION 
Overall, this study provides further evidence that the NMDAR subunit 
composition in the AVPV changes as function of age. The increase in NR1/NR2b 
fraction volume, along with a decline in the density of cells expressing NR2b, 
suggests a cell-specific change in receptor stoichiometry, likely resulting in 
functional effects exerted on the reproductive axis. In addition, estradiol 
modulated the fraction volume of NR2b expression. As receptor stoichiometry 
determines the functional kinetics of the channel, age-associated alterations in 
NMDAR composition suggest a mechanism whereby alterations to the GnRH 
system, whether indirect, direct, or a combination, may result in age-associated 
changes to GnRH output, affecting overall reproductive function.  
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Chapter 6. General Discussion 
 
This dissertation has focused on understanding the role of the NMDAR-
NR2b subunit in the onset of reproductive senescence, and its modulation by 
steroid hormones, in female rats. The first two experiments (chapters 3 and 4) 
focused on the physiological implications of the NR2b subunit on the regulation 
of LH pulsatile release and the estradiol-induced LH surge, respectively, two 
mechanisms essential for proper reproductive function in females. In the first 
experiment (chapter 3), examining LH pulsatile release, the NR2b antagonist, 
ifenprodil, was administered to both young and middle-aged, ovariectomized 
females given either vehicle or 17β-estradiol treatment. Ifenprodil had a robust 
effect in both young and middle-aged 17β-estradiol treated animals, causing an 
increase in LH pulse amplitude, LH area under the curve, and mean LH levels. 
Whereas in this group, GnRH mRNA was not affected, vehicle treated, middle-
aged animals showed a slight decline, suggesting a differential regulation of 
GnRH gene expression and LH release. As a whole, the data suggest that 
NMDARs containing the NR2b subunit influence pulsatile LH release, and 
further, that this activity is exerted only in the presence of estradiol. 
In the second experiment, effects of ifenprodil administration were 
examined in middle-aged, ovariectomized, 17β-estradiol treated females during 
the estradiol-induced LH surge. I discovered that the reproductive status prior to 
ovariectomy influenced the outcomes. Animals previously acyclic prior to 
ovariectomy showed no effect of ifenprodil. However, those that had been 
exhibiting irregular estrous cycles had an apparent advancement of the LH 
surge. Due to experimental limitations, the sample size was too small to attain 
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statistical significance. However, these preliminary data suggest a role for the 
NR2b-containing NMDARs in the proper timing and coordination of this event.  
Finally in the third experiment (chapter 5), I examined the population of 
NR2b subunits in the anteroventral periventricular (AVPV) nucleus of the 
hypothalamus. This nucleus is essential for proper reproductive cycling and 
ovulation (Wiegand et al., 1980), and is rich with projections to and from GnRH 
neurons, providing a means of integration of various neuronal signals important 
for reproductive behavior and function (reviewed in (Simerly, 2002)). Thus, I 
examined age and hormone associated changes to this population. Further, I 
studied alterations to the NR1 subunit population, and the coexpression of these 
subunits, as studies suggest that the co-expression of NR2b with NR1 is 
necessary for a functional channel (Kutsuwada et al., 1992; Monyer et al., 1992a, 
b; Sheng et al., 1994; Chen et al., 1999). Results showed an age-associated 
decrease in NR2b subunit density, with no change to the AVPV volume or NR2b 
immunoreactive cell number, but an age-associated increase in the co-
expression of NR1 and NR2b (as measured by the fraction volume of 
immunofluorescence), with no change in NR1 or NR2b alone. Further, the NR2b 
fraction volume of immunofluorescence increased with 17β-estradiol treatment. 
Together, I interpret these data to mean that, while there is an overall decline in 
the density of cells containing the NR2b subunit, those cells that do contain 
NR2b express more of it in the form of functional NR1/NR2b receptor.  
Finally, during this experiment, it was noted that, while populations of NR1 
immunofluorescent subunits were apparent in the absence of NR2b 
coexpression, the opposite was not observed in great abundance. Thus, in the 
AVPV, NR2b subunits appear to occur to a large degree only in the presence of 
the NR1, suggesting that changes to this population are likely functional. This is 
the first study to demonstrate this in the hypothalamus, and these results may 
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have important implications for past and future studies examining the NR2b 
subunit, including that of Miller & Gore (Miller and Gore, 2002). In that previous 
study, the coexpression of the NR2b subunit was shown to increase on GnRH 
neurons with age in the OVLT-POA, a region encompassing the AVPV, as it is 
likely that this increase is a functional one. 
Over the last fifty years, there have been great strides made in 
understanding the reproductive system. This field has progressed from a very 
isolated view of the reproductive axis, in which only GnRH, gonadotropins, and 
steroid hormones were considered, to a broader view that includes the regulatory 
neuronal network modulating this axis via GnRH neurons.  Further, the idea that 
reproductive decline results from ovarian follicular degeneration has been 
expanded to include contributions of neuroendocrine changes at the level of this 
neural network. 
Currently, there are a number of neuromodulators known to be involved in 
the neural control of GnRH release (reviewed extensively in (Gore, 2002b)). 
However, our understanding of the extent to which this modulation changes with 
age, and the mechanism by which this occurs, is limited. In this dissertation, I 
focused on the NMDAR, which plays a strong role in the regulation of the 
reproductive system throughout development and the transition to reproductive 
senescence (reviewed in (Brann and Mahesh, 1994; Brann, 1995; Moguilevsky 
and Wuttke, 2001; Brann and Mahesh, 2005; Parent et al., 2005)). My 
dissertation combined a pharmacological approach together with the 
measurement of physiological outcomes – that is, the prior reproductive status of 
each animal was known at the onset of experimentation, and thus, the 
experimental outcomes could be related back to both age and reproductive 
cyclicity. In this study, I focused on one specific NMDAR subunit, NR2b. Previous 
studies in the Gore laboratory have shown an age-associated change in the 
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mRNA expression of this subunit in the rostral hypothalamus (POA-AH) (Gore et 
al., 2000a; Gore et al., 2002), as well as an age-related increase in the 
coexpression of NR2b protein on GnRH neurons (Miller and Gore, 2002). Finally, 
this is a dynamic receptor, showing changes in multiple brain regions, including 
the hypothalamus, during important life transitions (Sheng et al., 1994; Adams et 
al., 1999; Gore et al., 2000a; Kuehl-Kovarik et al., 2000; Adams et al., 2001a; 
Adams et al., 2001b; Gore et al., 2002; Miller and Gore, 2002). The purpose of 
this dissertation was to further localize these changes, and to examine their 
physiological consequences pertaining to the onset of reproductive senscence.  
 
Physiological implications of the NMDAR-NR2b subunit in reproductive 
aging 
During the reproductive transition, GnRH release in vitro and LH release in 
vivo decline (Arslan et al., 1988; Bourguignon et al., 1989b; Donoso et al., 1990; 
Brann and Mahesh, 1992; Arias et al., 1993; Ping et al., 1994a, 1995; Arias et al., 
1996; Bonavera et al., 1998). Accordingly, parameters of pulsatile release 
change, with a decrease in pulse amplitude and an increase in interpulse 
intervals (Scarbrough and Wise, 1990). Further, there is a delay and attenuation 
of the LH surge in middle-aged female rats (Wise, 1982). 
Glutamate, acting via NMDARs, affects both of these events. Blockade of 
NMDARs results in a decline in LH pulse amplitude (Arslan et al., 1988; Ping et 
al., 1994b; Ping et al., 1995) and a blockade of the preovulatory LH surge 
(Suzuki et al., 1995). Further, administration of NMDA to ARC/ME fragments 
taken on the afternoon of proestrus results in an attenuated increase in GnRH 
release in middle-aged female rats compared to young (Zuo et al., 1996).  
Hence, the findings of this dissertation, in which ifenprodil administration resulted 
in an increase in LH release and pulse amplitude in both age groups, and a 
possible acceleration of the LH surge in middle-aged females, suggest that 
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NMDARs containing the NR2b subunit may play a different functional role in the 
modulation of these events than those lacking this subunit. This may be via an 
indirect action on GnRH neurons, such as disinhibition of GABA receptors, which 
are largely inhibitory to GnRH release. Alternatively, it may be that the differing 
channel kinetics conferred onto NR2b-containing receptors cause an alteration to 
receptor activity, such that the receptor itself may be inhibitory to GnRH neurons 
or the circuitry regulating them. 
 
Indirect actions of NMDARs: the GABA-glutamate connection 
The idea of interplay between glutamate and GABA in the regulation of the 
GnRH system is not novel. This is a well-established, complex interaction that 
undergoes developmental changes. During early development, these systems 
likely regulate one another in the hypothalamus to ensure a proper level of 
excitatory/inhibitory activity (Gao et al., 1998; van den Pol et al., 1998). The 
GABA system develops prior to glutamate in the embryonic rat. Once the 
glutamatergic system begins to develop, its development occurs more slowly 
(van den Pol et al., 1995; Gao et al., 1998; van den Pol et al., 1998). GABA 
appears to facilitate glutamatergic depolarization during this period (E15-E18), 
and once established, it is hypothesized that the glutamatergic system becomes 
the main excitatory component and the GABAergic system switches to become 
the main inhibitory drive. (Gao et al., 1998; van den Pol et al., 1998).  
In addition, from P15-P30 there is a transition in hypothalamic GABAergic 
regulation, from a stimulatory to inhibitory action. Furthermore, during this time 
the reproductive axis is undergoing a very important change from quiescent to 
active, as the period from P25-P30 represents the onset of puberty (Moguilevsky 
et al., 1991; Feleder et al., 1996; Moguilevsky and Wuttke, 2001; Carbone et al., 
2002; Han et al., 2002). The GABAergic system interacts with the glutamatergic 
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system during this transition to regulate the activity of the reproductive axis and 
influence these hypothalamic hormonal changes (Donoso et al., 1994; 
Moguilevsky and Wuttke, 2001; Clarkson and Herbison, 2006).  
This interaction continues into adulthood. Various regions of the brain 
show glutamate-stimulated release of GABA (do Nascimento and de Mello, 1985; 
Moran et al., 1986; de Mello et al., 1988; Harris and Miller, 1989; Pin and 
Bockaert, 1989), including the preoptic area of the female rat (as measured from 
synaptosomes in culture). This is enhanced by steroid hormone treatment 
(Fleischmann et al., 1992). Further, activation of GABAARs using the GABAAR 
agonist muscimol resulted in both increased GABA and glutamate release from 
this same in vitro preparation from males (Fleischmann et al., 1995). Further, the 
NMDA-facilitated GnRH/LH surge is inhibited by administration of muscimol 
(Akema and Kimura, 1993), further suggesting regulation of NMDAR activity by 
GABA.  
Finally, there is evidence of a dual-phenotype GABA/glutamate neuronal 
population in the AVPV of the rat (Ottem et al., 2004). Ottem et al. (Ottem et al., 
2004) used both in situ hybridization histochemistry and immunohistochemistry to 
show that the majority of neurons in the AVPV that express vesicular glutamate 
transporter (VGlut), a marker of glutamate, also express vesicular GABA 
transporter (VGAT), a marker of GABA, and vice-versa. Additionally, these dual-
phenotype neurons strongly express ERα, they have contacts on GnRH neurons, 
and their glutamatergic-GABAergic phenotype is estradiol-sensitive. Specifically, 
during the estradiol-induced LH surge, the VGAT-containing vesicles decreased 
while VGlut-containing vesicles increased during the afternoon transition to the 
surge, suggesting an increase in glutamatergic, and decrease in GABAergic, 
activity during this event (Ottem et al., 2004). However, this relationship has 
never been examined during aging. 
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Taking this evidence into account, it is very likely that the data presented 
in this dissertation provides further evidence for the possibility of a close 
interaction of these two neurotransmitter systems during reproductive aging. I 
hypothesize that the likely mechanism whereby antagonism of NR2b-containing 
NMDARs leads to enhancement of the LH pulsatile response and acceleration of 
the LH surge is via indirect actions of the NMDAR on GnRH neurons through 
GABAergic regulation. The finding that the density of NR2b-immunoreactive cells 
decreases with age in the AVPV, but that the amount of NR2b contained within 
these cells increases, suggests that certain cell populations in this nucleus are 
experiencing a change to NMDAR channel kinetics. As the presence of the NR2b 
receptor appears to increase the duration of the channel open period as 
compared to NR2a-containing receptors, I suggest that NMDARs expressed on 
GABAergic neurons are specifically undergoing this change in subunit 
composition, such that their existing NMDARs have an increase in NR1/NR2b 
co-expression. The result of this differential stoichiometry would be that GABA 
neurons, once activated, are open longer, increasing the amount of GABA 
released. This then binds to GABA receptors on the GnRH neurons, causing 
further inhibition and a decrease in GnRH release. Consistent with this idea, 
Neal-Perry et al. (2008) recently demonstrated that GABA levels in the 
hypothalamus are higher in middle-aged than in young rats. Further experiments 
are needed to test this possibility, including using GABA antagonists in concert 
with ifenprodil to determine whether there is indeed an interaction between 
GABA and glutamate, and an underlying role of the NR2b subunit.  
 
Direct actions of NMDARs  
Whereas the previous section discusses a multitude of studies supporting 
the interaction of GABA and glutamate, and therefore offers support for indirect 
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actions of NMDAR-NR2b regulation of the aging reproductive axis observed in 
this dissertation, there remains the possibility of direct actions of glutamate on 
the GnRH neurons. NMDARs, and their respective NR1, NR2a, and NR2b 
subunits, are expressed on GnRH neurons (Eyigor and Jennes, 1996, 1997; 
Gore et al., 2000a; Miller and Gore, 2002), and a subpopulation increase 
expression of the NR2b subunit with age (Miller and Gore, 2002). Additionally, 
this dissertation suggests that the amount of functional NR1/NR2b in the AVPV 
increases with age, and that blockade of NR2b-containing NMDARs, results in an 
enhancement of LH pulsatile release and may accelerate the LH surge. 
Therefore, it may be that the differing channel kinetics conferred onto NR2b-
containing receptors cause an alteration to receptor activity, such that the 
receptor itself may be inhibitory to GnRH neurons or the circuitry regulating them. 
This can be further investigated using electrophysiological approaches.  
Although a novel idea for the NMDAR, this is not the first instance in which 
a receptor would demonstrate a function opposite to that which is expected. 
Although GABA is still attributed with the major inhibitory actions in the adult 
hypothalamus, recent research suggests that at least a subpopulation of GABA 
neurons can continue to exert excitatory influences on the GnRH system in 
adulthood at least in some cases (DeFazio et al., 2002; Moenter and DeFazio, 
2005; Yin et al., 2008) but not others (Han et al., 2002). Although this has yet to 
be examined, I suspect that these contradictory actions are due to varying 
receptor stoichiometries of the GABA receptor, leading to varying channel 
kinetics. This same pattern may be occurring in the NMDAR, causing the results 
observed with ifenprodil application.  
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Estradiol effects on NR2b action and expression patterns 
While the focus of this dissertation was on the age-associated effects of 
the NMDAR-NR2b subunit on reproductive senescence, it was important to 
investigate the effects of estradiol in this respect. Estradiol levels decline in 
women, primates, and mice during the transition to reproductive aging, whereas 
the rat, which does not experience ovarian follicular degeneration, does not 
experience a drastic decline until later in life (reviewed in (Maffucci and Gore, 
2005)). Nevertheless, estradiol enhances actions of NMDAR agonists on the 
GnRH system in rats (Arias et al., 1993), and it also increases mRNA expression 
of NMDAR subunits in hypothalamic nuclei (Brann et al., 1993a; Gu et al., 1999; 
Gore et al., 2002; Ottem et al., 2002). Thus, I was interested in how estradiol 
further modulates both the anatomical expression of the NR2b subunit, as well as 
its actions on the reproductive axis.  
Interestingly, the presence of estradiol appears to play a large role in the 
endpoints examined in this dissertation. Whereas vehicle (cholesterol) treated 
females did not show a significant increase in LH pulse parameters following 
ifenprodil administration, estradiol-treated females showed a robust and 
significant increase in both age groups. Further, ifenprodil administration given 
on the morning of the estradiol-induced LH surge appears to accelerate the 
timing of the surge in animals previously irregularly cycling prior to ovariectomy. 
These studies support the enhancement of estradiol on NMDAR actions. Finally, 
whereas estradiol did not change the NR2b-immunoreactive cell population, 
similar to a previously published study on the NR1 AVPV population 
(Chakraborty et al., 2003b), it did cause an increase in the fraction volume of 
immunofluorescent NR2b, suggesting an estradiol-induced increase in the 
amount of NR2b expressed in the AVPV. A previous study by Brann et al. (Brann 
et al., 1993a) found that estradiol does not alter the binding of glutamate to its 
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receptors in the cortex or hypothalamus. That, together with these findings, 
suggests that this increase is due to post-translational modification of the NR2b 
subunit, resulting in increased NR2b protein volume. Evidence of high 
coexpression of NR1 and ERα support a mechanism by which this can occur 
(Chakraborty et al., 2003a), as estradiol and glutamate can converge upon the 
same target cells. Thus, estradiol binding results in enhanced protein translation 
of the NR2b subunit, an effect that can have functional consequences on the 
target GnRH neurons.  
 
CONCLUSION 
Taken together, these three studies show a developing story in which 
dynamic changes in NMDAR stoichiometry throughout the life cycle result in 
changes in GnRH function, and ultimately, contribute to the transition to 
reproductive senescence. In particular, the NR2b appears to play a key role in 
modulating the function of NMDARs involved in both direct and indirect regulation 
of GnRH properties. Future research should investigate, in particular, the 
interactions among GABA, glutamate, and GnRH cells in the transition to 
reproductive failure. This will provide additional therapeutic targets for the 
treatment of central nervous system disorders associated with menopause, and 
facilitate quality of life for women who undergo this inevitable life process. 
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